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GENERAL INTRODUCTION 
Transmissible gastroenteritis (TGE) of swine was first described 
by Doyle and Hutchings in 1946. Transmissible gastroenteritis is a 
highly contagious viral enteric disease in pigs. It can affect animals 
of all ages; however, its most serious losses occur in pigs younger 
than 2 weeks of age. The symptoms are severe watery diarrhea, vomiting 
and dehydration. Death normally occurs within 2-5 days of the first 
clinical signs. Mortality in younger pigs can reach as high as 100%. 
Whereas, mortality in 2 to 6 month-old pigs is 25-30%. 
The pathogen is viral and is of one serotype. It has been classified 
in the coronavirus group and is a pleomorphic virus. Transmissible 
gastroenteritis virus (TGEV) is a single stranded RNA virus poly-
adenylated at the 3'-terminus and is presumed to be of positive polarity. 
It replicates through double stranded RNA replicative intermediaries. 
The primary lesions in young animals that are infected with TGE 
are found in the small intestine which is distended with gas and 
yellowish watery fluid. The most severe lesions are found in the 
jejunum. The intestinal wall becomes very thin and almost transparent. 
TGEV is known to attack the mature absorptive cells of the intestinal 
villi. The result is severe atrophy of the villi and replacement of 
the columnar epithelium with cuboidal cells. The virus begins its 
invasion approximately 5 hours after infection. The virus replicates 
in the absorptive epithelial cells and matures by budding at smooth 
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cellular membranes. Stripping of the villi epithelium leads to 
maldigestion and malabsorption of food. 
The presence of cell—mediated immunity (CMI) in TGEV-infected 
pigs has been demonstrated by several groups. Cell-mediated immunity is 
undoubtedly present with a TGEV infection. Its involvement or significance 
at this point is uncertain and surely needs to be investigated more 
thoroughly. 
It is known that maternal Ig in sows is normally not transferred 
through the placenta. Therefore, virtually no immunoglobulins are 
present in the fetus. For the suckling piglet, protection against 
TGE infection depends upon the constant presence of immunoglobulin on 
the mucosal surface derived from colostrum and milk. 
Transmissible gastroenteritis is economically a very important 
disease to the pork industry. At this point in time a vaccine is 
needed which will elicit lactogenic immunity. The safest approach 
would be a subunit vaccine since TGE is such a highly contagious 
disease. 
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DISSERTATION FORMAT 
This dissertation is presented in an alternate format which 
includes three manuscripts to be submitted to scientific journals for 
publication. One manuscript will be submitted to the American Journal 
of Veterinary Research and one to the Journal of Infection and Immunity 
and the last to be sent to the Canadian Journal of Microbiology. The 
manuscripts are presented in the format required for the dissertation. 
References are cited at the end of each manuscript and are in compliance 
with the respective journal. The manuscripts are preceded by a general 
introduction. A general discussion and conclusion section follows the 
third and last manuscript. 
The Ph.D candidate, Michael Alex Sagona, was the principal investi­
gator for each of the investigations and is the senior author for each 
of the manuscripts. Dr. P. M. Cough served as major professor and 
co-author on all manuscripts. 
vii 
OBJECTIVES 
The objectives of this investigation were to: 
1) Characterize an immunogenic TGE subunit glycoprotein as far 
as properties of significance to its isolation and purification. 
2) Establish an iji vitro correlate to determine the amount of 
cell-mediated response elicited by immunizing with the 
glycoprotein. 
3) Identify the presence of CMI in the intestinal tract of swine 
vaccinated with the glycoprotein viral subunit. 
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LITERATURE REVIEW 
Etiology 
Transmissible gastroenteritis (TGE) of swine, a highly contagious 
enteric disease, was first described by Doyle and Hutchings in 1946. 
It can affect pigs of all ages but the most serious losses occur in 
pigs younger than 2 weeks of age. These animals suffer from severe 
watery diarrhea, vomiting and dehydration, and the mortality with TGE 
can reach as high as 100%. Bachmann et al. (1972) reported a 25-30% 
mortality in 2 to 6 month-old pigs. Therefore, TGE is of high economic 
importance in the swine industry. 
The viral etiology of TGE was first suggested by the work of Doyle 
and Hutchings (1946). McClurkin and Norman (1966) proposed that more 
than one viral agent was involved in the disease but it is now generally 
accepted that there is only a single virus involved. The pathogen which 
causes the disease is apparently of one serotype and is classified in 
the coronavirus group (Bohl et al., 1969; Tajima, 1970). Transmissible 
gastroenteritis virus (TGEV) has been propagated in cell cultures prepared 
from porcine kidney (Lee, 1956), testis (McClurkin and Norman, 1966), 
thyroid gland, and salivary gland (Witte and Easterday, 1967) and in 
embryonated eggs (Eto et al., 1962) and canine kidney cells (Welter, 
1965). It is single-stranded RNA virus. Recent studies indicate 
that the approximately 5.5 x 10^ dalton nucleic acid of coronaviruses 
is polyadenylated at the 3'-terminus and is presumed to be of positive 
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polarity (Lai and Stohlman, 1978; Schochetman et al., 1977; Wege et al., 
1978). Information on the biochemistry of the viral polypeptides , with 
the exception of an internal polypeptide associated with the RNA, tends 
to vary according to the strains studied. The nucleoprotein in all 
cases studied so far appears to have a molecular weight of approximately 
50,000 (Tyrrell et al., 1978; Robb and Bond, 1979). 
Transmissible gastroenteritis virus is well-adapted to conditions 
within the gastrointestinal tract. It is extremely stable at pH 3, 
enabling it to survive the acidity of the stomach. Haelterman (1972) 
discovered that the titer of the virus decreased only 2 logs after 
exposure to pH 2 for 30 minutes. It is resistant Co trypsin treatment 
(Cartwright et al., 1965) but is inactivated by lipid solvents (Pensaert 
et al., 1970). Transmissible gastroenteritis virus replicates rapidly, 
producing lesions in the small intestine, primarily the jejunum, but 
usually not affecting the stomach or the colon. Haelterman (1972) 
suggested that bile may perhaps be a consideration in protecting the 
duodenum from attack by TGEV. The virus may be found in many organs 
such as the nasal mucosa, tonsil, trachea, lung, liver, and the kidney. 
However, it does not produce lesions in these tissues. 
Pathology 
Transmissible gastroenteritis virus attacks the mature absorptive 
cells of the intestinal villi. The primary lesions in animals affected 
with the TGE coronavirus are found in the small intestine which becomes 
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distended with gas and a watery yellowish fluid. The intestinal wall 
becomes thin and almost transparent. Okaniwa and Maeda (1965) 
reported the occurrence of swollen lymph nodes and splenomegaly with 
TGEV infection. Older animals usually have less severe lesions than 
those found in younger animals. Moon (1971) attributed this to the 
fact that absorptive cells remain on the intestinal villi considerably 
longer (7-10 days) in young pigs than in older pigs (2-4 days) and TGEV 
has a greater affinity for old cells than for young cells. He also 
suggested that older pigs replace the damaged epithelium much faster 
than do younger pigs. 
At approximately 5 hours post-infection (PI) the TGEV begins to 
attack the villous epithelium (Pensaert et al., 1970). The virus 
attacks the majority of the villous epithelial cells but spares the 
crypt epithelium. The affected cells slough-off and villous atrophy 
occurs when replacement of epithelium from the crypts cannot keep up 
with the loss by sloughing. Degeneration and desquamation of intestinal 
epithelium occurs between 9 and 12 hours PI and severe atrophy of the 
villi and replacement of the columnar epithelium with cuboidal cells 
develops thereafter. The most severe lesions are located in the jejunum. 
The villous cell to crypt cell ratio may decrease from 7:1 to less than 
1:1 (Hooper and Haelterman, 1966) due to a combination of villous atrophy 
and hyperplasia of crypt epithelium. 
Other viral enteric diseases which are characterized by similar 
villous atrophy include: rotavirus infection in calves (Mebus et al.. 
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1971) and in swine (Rodger et al., 1975) epizootic diarrhea of infant 
mice (Adams and Kraft, 1968) and panleukopenia in cats (Johnson, 1967). 
Factors which are involved in the mechanism of diarrhea include: 
hypermotility, hypersecretion, malabsorption, and increased permeability 
(Moon, 1978). There is much evidence supporting the last three factors 
as being involved in the diarrhea associated with TGEV infection. 
Since the damaged and renewed epithelial cells following villous atrophy 
are deficient in normal cellular enzymes (Thake, 1968) diarrhea results 
from malabsorption and maldigestion. With TGEV infection a decrease 
in levels of succinic dehydrogenase takes place; this may indicate that 
the mitochondria have been damaged. Also,.a decrease in alkaline phos­
phatase activity is observed, resulting in a decrease in digestive-
absorptive capacity. The maldigestion occurs due to a lactase deficiency 
(Cross and Bohl, 1968). 
Kelly et al. (1972) discovered that the sodium-potassium-ATPase 
activity in the jejunum is decreased in TGEV-infected pigs and this 
decreased activity is accompanied by an increased secretion of sodium, 
potassium and chloride from the cells of the intestine. Butler et al. 
(1974) confirmed that sodium efflux is increased in TGEV infected villi, 
and suggested that the undifferentiated absorptive cells of the 
replaced villi may retain the Inherent secretory ability of crypt cells 
and thereby contribute to the diarrhea. In addition to this, the 
osmotic pressure is increased through fermentation of the maldigested 
food and fluid is pulled into the lumen of the intestine. Shepherd 
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et al. (1979) found that at the height of TGE diarrhea short-circuited 
ileal epithelium failed actively to transport Na^ and CI and also 
there was a defect of glucose-mediated Na^ transport. They demonstrated 
in vitro that a specific defect of glucose-stimulated sodium transport 
is a defect that coincides with the presence of immature crypt-like 
enterocytes on the villous epithelium. 
Immunity 
Humoral It is commonly accepted that swine which recover from 
TGEV infection are protected from clinical disease upon subsequent 
exposure to the pathogen. However, Bohl (1975) pointed out that the 
immunity is incomplete, especially when the pig is infected when 
young or is challenged with a large dose of virus several months PI. 
Harada et al. (1969) discovered that although intramuscular (IM) injection 
with TGEV produced a high titer of circulating neutralizing antibody, 
it did not protect recipients from challenge. Circulating antibodies 
provide very little, if any, protection to animals against intestinal 
infection, whereas secretory antibodies do (Bohl and Saif, 1975). 
Stepanek et al. (1971) demonstrated that virus-neutralizing 
antibody occurred in sows 16 days after natural infection with TGEV 
and reached a peak at 35 days. All of the piglets nursing these sows 
were protected against challenge. Antibody in the colostrum and milk 
was implicated as a primary factor in this protection. Virtually no 
immunoglobulins are present in a porcine fetus since maternal 
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immunoglobulins do not pass through the placenta. In porcine serum 
the concentration of IgA and IgM are approximately equal but in colostrum 
there is three times as much IgA as IgM. The concentration of immuno­
globulins decreases about 10-fold during the first few days of lactation, 
and in the milk, IgA becomes the predominant immunoglobulin (Bourne, 
1976). The origin of the immunoglobulins is different in colostrum than 
in milk. Bourne and Curtis (1973) found that all colostral IgG was 
derived from serum but 60% of colostral IgA was produced locally. In 
milk over 90% of the IgA and IgM and 70% of the IgG were produced 
locally. 
Bohl et al. (1972) indicated that intramuscular (IM) injection 
of TGEV into gilts resulted in high serum and colostral IgG titers but 
very low titers of IgA. Natural infection of gilts stimulated high 
serum, colostral and milk IgA titers. Piglets nursed by sows naturally 
infected were protected from TGEV infections, whereas, those nursed by 
IM-vaccinated sows were not. 
Although IgA is considered to be the best immunoglobulin for 
preventing most intestinal infections. Porter et al. (1979) feel that, 
in the case of lactogenic immunity, IgA is a somewhat overworked 
concept and that IgM should also be taken into account, especially 
in adoptive immunization of the neonate. Protection against TGEV 
infection depends upon the constant presence of specific antibody in 
the intestinal lumen. Porter et al. (1979) report that in the neonatal 
pig less than 5% of the lis IgA ingested is absorbed across the intestine 
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when compared to 9S and 7S IgA lacking secretory component. They also 
stated that the role of maternal milk IIS IgA antibody is entirely 
lumenal and continues to be so throughout lactation. 
Allen and Porter (1973) found IgA-containing cells in the intestinal 
lamina propria of pigs over 2 weeks of age. Brown and Bourne (1976) 
discovered that IgM-producing cells are somewhat more numerous than 
IgA-producing cells in the lamina propria during the first 3 weeks of 
age and that IgA-producing cells became more numerous after 3 weeks. 
Allen and Porter (1973) made similar observations for the gastric 
mucosa of young pigs. Obviously the immune defense system in piglets 
before maturation of lymphoid tissue depends upon passive immunity. 
Cell-mediated immunity (Oil) 
Chu et al. (1979a) studied interepithelial (lEL) and Peyer's patch 
(PP) lymphocytes in 6 different portions of the small intestine of pigs 
ages of 0 (4-10 hrs), 1, 5, 15 and 31 days. They found that the numbers 
of IEL increased significantly from 3.3 ± 0.6 per 100 absorptive 
epithelial cells at 0 day of age to 38.9 ± 3.5 at 31 days. In all age 
groups most of the lEL were found in the subnuclear level of absorptive 
epithelial cells. As the animals matured, the numbers of supranuclear 
lEL increased and subnuclear lEL decreased while nuclear level lEL 
remained stable. They reported that small PP with relatively well-defined 
germinal centers and loosely arranged domes were observed in the 
youngest group of pigs. The size of the lymphoid nodules increased 
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several times during the interval between day 0 and 31 days of age. 
Frederick and Eohl (1976) first demonstrated that cell-mediated 
immunity (CMI) to TGEV occurs in infected pigs. They discovered that, 
in most of their experimental animals, the migration inhibition factor 
(MIF) for macrophages was produced by lymphocytes of the lamina propria 
of the small intestine as well as by splenic lymphocytes. Following 
oral inoculation of TGEV, lymphocytes of the lamina propria produced 
more MIF than did splenic lymphocytes. Following subcutaneous inocu­
lation the opposite result was seen. Woods (1977) determined that, 
with TGEV, MIF appeared at 7 days PI and lasted at least 35 days. He 
also demonstrated CMI against TGE virus by using a leukocyte aggregation 
assay (Woods, 1976). This test is based on the presence of long-term 
recirculating memory lymphocytes. 
Shimizu and Shimizu (1979a) demonstrated cytotoxic lymphocytes to 
virus-infected target cells in pigs which were orally exposed to TGEV. 
On post-inoculation day 7 they found cytotoxic lymphocytes in Peyer's 
patches, mesenteric lymph nodes, spleen and peripheral blood. The 
cytotoxic activity increased thereafter and reached a maximum at 21 
days PI. Lymphocytic cytotoxicity was depressed by treating effector 
cells with anti-porcine thymocyte serum. 
Shimizu and Shimizu (1979b) also demonstrated an iji vitro lymphocyte 
proliferative response to viral antigen. Lymphocytes reactive to 
the viral antigen were isolated from Peyer's patches, mesenteric lymph 
nodes, spleen and peripheral blood. These reactive lymphocytes were 
taken from pigs which were infected orally with TGEV and were first 
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detected in all the tissues of pigs tested on post-inoculation day 7. 
Thereafter, they increased in proliferative reactivity and reached a 
maximum on PI days 10 to 14. Antigen-reactive cells were demonstrated 
persistently in Beyer's patches and mesenteric lymph nodes for at least 
110 days after inoculation. Splenic and peripheral blood cells were 
found to have only transient proliferative reactivity. No antigen-
reactive cells were detected in either the spleen or peripheral blood 
after PI days 20 to 30. Reactivity to viral antigen and the mitogen 
phytohemagglutinin (PHA) was decreased markedly after treatment of 
lymphocytes with anti-porcine thymocyte serum and complement. Lymphocytes 
reactive to the viral antigen and PHA belonged mainly to the erythrocyte 
rosette-forming cell fraction. 
Chu et al. (1979b) studied the number and distribution of lymphocytes 
in the small intestine of immunocompetent 8-week-old swine during 
TGEV infection. They observed that there was no difference in the 
numbers of lEL between controls and TGEV-infected pigs at 12 and 18 hr 
PI. However, at 24 hr PI a significant decreased occurred in the 
number of IEL in the duodenum and anterior jejunum and an increased 
number appeared at the nuclear level of the intestinal epithelium of 
infected animals. Chu et al. (1979b) found that the numbers and distri­
bution of lEL were unchanged in the middle jejunum and the ileum. They 
revealed, through electron microscopy, that membranous (M) cells and 
ordinary microvillus-covered epithelial (MC) cells in the dome epithelium 
embraced one or more lymphocytes, and formed a specialized cell complex 
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or dome epithelium (DE) complex. They concluded that most of the 
lymphocytes were in a very active state because of the large number 
of organelles in the cell. 
The vitro proliferative response of lymphocytes to specific 
antigens has been considered to be one of the ^  vitro correlates of 
CMI (Valentine, 1971). Experiments in vitro enable measured quantities 
of lymphocytes from select populations (i.e. lymph node, spleen, 
peripheral blood) to be directly exposed to known amounts of antigen 
in an isolated and controlled environment. In this way, it is not 
necessary to reexpose the cell donor to the antigen. These techniques 
are particularly desirable for the study of cellular immunology in 
humans. 
Lymphocyte suspensions from humans, monkeys, rabbits, guinea pigs, 
mice, chickens and pigs have been placed in short term tissue culture 
and their proliferative response to antigens measured. Suspensions of 
lymphoid cells have been stimulated by a large variety of antigens such 
as: viruses, bacteria, transplantation antigens, proteins, glycoproteins, 
pollens, synthetic amino acid polymers and certain drugs. Lymphocyte 
transformation stimulated by antigen vitro occurs when the cell 
donor has been previously sensitized to the antigen. Although, the 
studies of Mishell and Button (1967) on the primary response to sheep 
erythrocytes ^  vitro suggest that cells dependent upon that proliferative 
response can produce specific antibody against the stimulating antigen, 
this system as generally employed measures a secondary, cellular 
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response to antigen in vitro (Valentine, 1971). This blastogenic 
response to antigen cannot be transferred to nonsensitive cells by 
pre-exposure to immune serum (Caron and Sarkany, 1966). 
In general, the transformation and proliferation of lymphocytes 
upon stimulation with antigen ^  vitro have been found to correlate 
with the presence of delayed type hypersensitivity in the cell donor 
(Mills, 1966; Oppenheim et al., 1967; Zweiman et al., 1966). Animais 
that have been immunized with antigens in Freund's complete adjuvant 
manifested delayed hypersensitivity and their lymphocytes underwent 
transformation when stimulated by antigens in vitro (Mills, 1966). 
There have been some reports, however, of in vitro transformation 
occurring with lymphocytes from animals immunized by methods which 
do not produce classical delayed hypersensitivity and with cells from 
donors with no delayed hypersensitivity reaction. Specific lymphocyte 
transformation has been obtained with node cells from guinea pigs which 
had negative skin tests for delayed hypersensitivity (Oppenheim, 1968) 
following immunization with alum-precipitated diphtheria toxoid. 
Furthermore, early studies by Button (1967), Button and Eady (1964) 
demonstrated that the vitro proliferative response of spleen cells 
from rabbits immunized intravenously with alum-precipitated proteins 
correlated with the development of the ability to make antibody i^ vivo. 
Guinea pig lymph node, spleen and peripheral blood lymphocytes have each 
produced an equal balstogenic response whether taken from animals. 
given sheep red blood cells by the intravenous route or from those 
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immunized with antigen and Freund's complete adjuvant (Loewi et al., 
1968). Blood lymphocytes from humans with immediate wheal-and-flare 
sensitivity to penicillin have been found to transform when cultured 
in vitro with penicillin (Fellner, 1967). Similar observations have been 
reported on the specific stimulation of lymphocytes from individuals 
with wheal-and-flare allergy to pollen (Brostoff and Roitt, 1969; 
Girard et al., 1967). 
Subunit vaccines 
Subviral vaccines are attracting much attention because of their 
safety features. Antigens of both viral envelopes and subviral infectious 
particles are known to elicit the formation of serum neutralizing 
antibody. 
The first subunit vaccine was looked at in 1969 in conjunction 
with the influenza virus and was known as the "split" influenza vaccine. 
The "split" influenza vaccine contained the immunogenic viral 
hemagglutinin and neuraminidase but excluded the pyrogenic component 
which was characteristic of the influenza whole virus vaccines. 
Clinical trials carried out by Rubin and Tint (1975) revealed that 
the immune responses of subunit vaccinates were equal to, if not better 
than, those achieved with whole virus vaccines. 
Morein et al. (1978) showed that the immunogenicity of viral 
subunit vaccines is dependent upon the integral proteins which are 
associated with the hydrophobic core of the phospholipid bilayer in 
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in membranes. Methods that facilitate the break-up of membranes into 
component parts that retain the native antigenic conformation have 
been essential to efficacy. Schafer and Bolognesi (1977) reported 
that monomeric forms of viral envelope proteins are not suitable for 
use in subunit vaccines because of poor immunogenicity and that water-
soluble monomers of envelope proteins do not elicit protective antibodies. 
Subunit vaccines prepared from nonenveloped viruses have not been as 
successful as those from enveloped viruses. With the adenoviruses, 
Neurath and Rubin (1971) found that antibodies directed against the 
pentons and fibers affect viral attachment to cells but, in order 
to achieve protection, neutralization of other antigenic sites also 
was required. 
Glycoproteins have been released selectively from the envelopes 
of the rhabdoviruses with nonionic detergents. Kelley et 9I. (1972) 
demonstrated that Triton X-100 treatment of vesicular stomatitis virus 
released glycoprotein G which induced specific serum neutralizing 
antibodies in rabbits, Wiktor et al. (1973), using Nonidet P-40 
(NP-40), solubilized glycoprotein G of rabies virus and with it elicited 
a serum neutralizing antibody response that protected rabbits and mice 
against a lethal challenge with virulent rabies virus. Cox et al. 
(1976) reported that the glycoprotein G from rabies virus purified by 
isoelectric focusing has been considered, theoretically, to be the ideal 
human vaccine due to its potency and its high degree of purity. 
One of the major problems of subunit vaccines is getting sufficient 
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quantities for immunizations. Sokol (1975) reported that there are 
three possible sources of viral subunit proteins; 1) virion preparations, 
2) viral antigens which are integrated into the infected cells and, 
3) soluble viral proteins secreted into cell culture fluids. Reed (1979) 
suggested three basic methods for large scale subunit production: 
1) large scale virus production followed by extraction and purification 
of the subunit immunogen, 2) synthesis of the specific immunogen by 
chemical means, 3) recombinant DNA technology. Reed (1979) also 
discussed the advantages and disadvantages of subunit vaccines. The 
advantages are: 1) safety - the procedures for making subunit vaccines 
eliminate infectious and possibly oncogenic material, 2) efficacy - large 
doses can be administered without adverse effects, 3) ability to identify 
vaccinates by the use of a second subunit as a diagnostic reagent. 
The major disadvantages of the subunit vaccine are: 1) adjuvants are 
required because subunits are soluble proteins or glycoproteins, 2) the 
subunit approach is costly; at this time commercial subunit vaccines are 
made by extraction procedures. 
Subunit components of coronaviruses 
Much research effort has been directed towards the comparison 
and identification of the structural proteins which comprise the various 
coronaviruses. Garwes and Pocock (1975) and Garwes et al. (1976) 
demonstrated that TGEV is composed of four major polypeptides with 
molecular ranges from 200,000 to 28,500. In addition, they also found 
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two minor polypeptides with molecular weights of 105,000 and 80,500. 
The largest polypeptide that they observed contained carbohydrate and 
was located in the viral surface projections. Bohac and Derbyshire 
(1975) found only three antigens following Immunoelectrophoresis of 
alkaline intestinal extracts prepared from piglets experimentally 
infected with TGEV. Two of these antigens migrated towards the anode 
and the third migrated towards the cathode. Antigens with anodal or 
cathodal mobility were demonstrated in the same materials by counter-
immunoelectrophoresis. 
Sturman (1977), and Sturman and Holmes (1977), studying the murine 
coronavirus A-59, observed six major polypeptides under standard 
conditions of sodium dodecyl sulfate - polyacrylamide gel electrophoresis 
(SDS-PAGE) but only four size classes if the proteins were solubilized 
at 25° or 37°C. Two species of polypeptides, GP38 (38,000) and 
GP60 (60,000), were found in SDS gels when the sample was prepared at 
100°C but not in similar gels when the sample was prepared at 25° or 
37°C. Sturman, Holmes and Behnke (1980) isolated two envelope glyco­
proteins and the viral nucleocapsid from the murine coronavirus A-59 
after solubilization of the viral membrane with NP-40. The isolated 
E2 glycoprotein (GP 180/90) consisted of rosettes of peplomers, whereas, 
the El glycoprotein (GP 23) was amorphous. Incubation of the NP-40 
disrupted virus at 37°C with the E 1 viral glycoprotein resulted in 
the formation of a complex between the viral nucleocapsid and the 
glycoprotein. This was related to a temperature-dependent conformational 
change that occurred in El. 
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Working with the murine coronavirus JHM, Wege et al. (1979) 
also revealed six polypeptides using SDS-PAGE. The molecular weights 
ranged from 170,000 to 22,700. Four of the polypeptides were glyco­
sylated. After limited proteolysis with pronase, analysis suggested 
that two of the glycoproteins are protruding from the lipid envelope 
and together with a third glycoprotein form the spike layer. Siddell 
et al. (1980) demonstrated that host cells Infected with the murine 
coronavirus JHM no longer synthesized host cell protein but rather 
synthesized polypeptides with molecular weights of 150,000, 60,000 
and 23,000. They Isolated a polyadenylated RNA from these Infected 
cells which directed the synthesis of both a 60,000 and 23,000 molecular 
weight polypeptides. 
Hajer and Storz (1978) demonstrated seven distinct bands of 
polypeptides after electrophoresis of SDS-solubilized bovine coronavirus 
LY-138, in polyacrylamide gels. The molecular weights of these poly­
peptides ranged from 110,000 to 36,000. Four of the bands were positive 
for the periodic acid-Schiff test, which indicated that they were 
glycoprotein in nature. 
Using a microimmunodlffusion technique, Yaseen and Johnson-
Lussenburg (1980) demonstrated six viral polypeptides from the human 
coronavirus 229E (MCV 229E). Of these six antigens three were 
identified as virus-specific and the rest as host materials. 
Hierholzer et al. (1972) also described six polypeptides con­
stituting the human coronavirus 0C43. The molecular weights ranged 
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from 191,000 to 15,000 daltons. Four of the six polypeptides contained 
carbohydrate and one contained lipid. Digestion of the viral projections 
with bromelin removed glycoproteins number 2 and 6. The association 
of a host cell antigen with the virion was confirmed by standard 
hemagglutination inhibition (HI) and complement fixation (CF) tests. 
MacNaughton (1980) as well as Yaseen and Johnson-Lussenburg 
(1980) feel that the confusion in the data for differences in poly­
peptides of coronaviruses is partially attributed to the variety of 
techniques used to study the various members. These techniques 
include methods for growth and purification of viruses and ultimately 
for the analysis of polypeptides. MacNaughton (1980) has suggested 
that in order for comparisons of structural polypeptides from different 
coronaviruses to be valid, the analysis should be accomplished in one 
laboratory. He performed this task with the human coronavirus 229E 
(HCV 229E) and the mouse hepatitis virus strain 3 (MHV3) and discovered 
that there were many similarities between the polypeptide patterns. 
Yaseen and Johnson-Lussenburg (1980) feel that the confusion is also 
due to the lack of a comprehensive study of these subunits in relation 
to their structural and biological functions. Also they believe that 
the incorporation of host components into the infectious virion 
(Hierholzer et al., 1972, Pike and Garwes, 1977) makes the characteriza­
tion of such antigens difficult because any procedure that is designed 
to give highly purified viral antigens may also succeed in removing 
nonvirion host components. 
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The articles included in this dissertation describe a TGE 
subunit glycoprotein which is proving to be an efficient immunogen 
against TGE in young pigs. After vaccination of pregnant sows, 
neutralizing antibody to TGE was disdovered in serum, colostrum and 
milk. Hence, the immunity provided to the suckling piglet is lactogenic. 
Gough et al. (unpublished data) found that piglets nursing sows 
vaccinated with this TGE subunit demonstrated 45% morbidity and 8% 
mortality upon challenge. Whereas, the control pigs showed 100% 
morbidity and 76% mortality when challenged with TGEV. 
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PART I: IN VITRO LYMPHOCYTE TRANSFORMATION WITH GLYCOPROTEIN 
SUBUNIT FROM TRANSMISSIBLE GASTROENTERITIS VIRUS (TGEV) 
This manuscript has been submitted for publication to the American 
Journal of Veterinary Research. 
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In Vitro Lymphocyte Transformation with Glycoprotein 
Subunit from Transmissible Gastroenteritis Virus (TGEV) 
Michael A. Sagona 
P. M. Gough 
From the Veterinary Medical Research Institute, College of Veterinary 
Medicine, Iowa State University, Ames, Iowa 50011. 
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SUMMARY 
A cellular immune response was demonstrated iji vitro when immune 
lymphocytes were cultured with a subviral glycoprotein component isolated 
from transmissible gastroenteritis (TGE) virus. Peripheral lymphocytes 
taken from immunized sows underwent blast transformation and incorporated 
3 ( H) thymidine into DNA when exposed iji vitro to the immunizing glyco­
protein agent. Serum and colostral antibody titers correlated very 
well with the degree of blast transformation from each animal. 
It appeared that the lymphocyte stimulation was T-cell related 
or dependent. An anti-porcine thymocyte serum, when added with complement, 
eliminated the activation of lymphocytes achieved with the glycoprotein 
as well as that achieved with the T-cell mitogens, phytohemagglutinin 
(PHA) and conconavalin A (Con A). 
Glycoprotein subviral component isolated from the Miller strain of 
TGE virus stimulated immune lymphocytes vitro that were initially 
sensitized by immunization with glycoprotein from the Illinois strain. 
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INTRODUCTION 
Cell mediated immunity (CMI) has been reported by many researchers 
dealing with viral infections. Transmissible gastroenteritis (TGE) 
of swine caused by a coronavirus appears to be no exception (Tajima, 
1970; Frederick and Bohl, 1976; Woods, 1977; Shimizu and Shimizu, 
1979a,b). Frederick and Bohl (1976) first described CMI to TGE virus in 
infected pigs. They revealed the production of macrophage migration 
inhibition factor (MIF) by lymphocytes. After oral inoculation with TGE 
virus, lymphocytes of the lamina propria (LP) produced more MIF than 
did the splenic lymphocytes. However, following subcutaneous inocula­
tions the splenic lymphocytes produced more MIF than did the LP 
lymphocytes. 
Harada et al. (1969) found that even though an intramuscular 
injection of TGE virus elicits a high titer of circulating antibody 
the animals were not protected from challenge, since an IM injection 
does not induce secretory antibodies. Circulating antibodies do not 
protect animals against TGE virus, whereas secretory antibodies do 
protect. Porter et al. (1973) using coli demonstrated that the 
class of colostral antibody was dependent upon the nature of the antigen, 
the route of administration and the timing of administration. 
Bohl et al. (1972) demonstrated that intramuscular injection of 
TGE virus into gilts resulted in high serum and colostral IgG titers, 
but very low titers of IgA. Natural infection of gilts stimulated 
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high serum and colostral IgA titers. 
Shimizu and Shimizu (1979a, 1979b) have demonstrated CMI following 
both TGE infection and inoculation with TGE viral antigen. Lymphocytes 
isolated from peripheral blood, spleen, Beyer's patches and mesenteric 
lymph nodes proliferated in response to the viral antigen and were 
cytotoxic to virus-infected target cells. Using a leukocyte aggregation 
assay, Woods (1977) also demonstrated a cell-mediated response to 
infection with TGE virus. This assay was based upon the presence of 
long term recirculating memory lymphocytes and was directed toward 
evaluation of the CMI concept. 
The present study was conducted to determine whether or not a 
cellular response exists in swine immunized intramuscularly with a 
subviral glycoprotein component from TGE virus. This component has 
been observed to be an effective immunogen in inducing lactogenic 
protection for suckling pigs. 
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MATERIALS AND METHODS 
Procedures 
Virus strains Illinois strain TGE virus was prepared as the 
supernatant fluid from a 10% (w/v) homogenized suspension of infected 
small Intestine from 3 to 5 day old piglets. The animals had received 
200 PID^ g of the virus orally and were killed when signs of disease 
became significant but before the pigs were moribund. 
Miller strain TGE virus was prepared by infecting swine testicle 
monolayers in cell culture. Approximately 3x10^  PFU of virus suspension 
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were seeded onto a 175 cm culture flask and allowed to absorb for 1 hr 
at 37°C in a humid 5% CO^ atmosphere. After this, 50 ml of Eagles 
minimum essential medium (EMEM) (Flow Labs., McLean, Virginia) were 
added. The virus was harvested 48 hrs later following three cycles of 
freeze-thawing. 
Purified virus of both strains was prepared by precipitation of 
virus in polyethylene glycol 6000 (PEG) (Eastman Kodak, Rochester, N.Y.) 
and saline. The precipitate was suspended in EMEM and whole virus was 
harvested following rate-zonal centrlfugation (Flow Chart, Fig, 1), 
Virus Neutralization Assay The sample was heat inactivated 
at 56° for 30 minutes. A positive and negative sample was included 
as controls. Dilution of the sample with tissue culture medium without 
serum was carried out to 1:15K. To each dilution was added an equal 
amount of titered and diluted virus and the tubes were swirled for 
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1 minute. The tubes were incubated in a 37°C water bath for 60 
minutes. Each well of a tissue culture plate was inoculated with 0.1 ml 
of sample and the plate was swirled to cover the surfaces with inocula. 
The plate was incubated for 1-1^ hrs at 37°C and then 4 ml of agar 
overlay were added. 
Glycoprotein preparation The virus was disrupted by high 
frequency sound with a Biosonic IV (VWR Scientific, San Francisco, 
Calif.) sonic oscillator and a glycoprotein component was collected 
following isopycnic ultracentrifugation and purified by gel filtration 
through Sephacryl S-200 (Pharmacia, Uppsala, Sweden). The preparation 
was chicked for live virus. 
Experimental animals Six first litter gilts were obtained from 
a specific pathogen free (SPF) herd and were seronegative for TGE. The 
pigs were of Duroc and Yorkshire breeding. 
Immunization schedule Immunization consisted of 1 ml of a 
1 mg/ml suspension of glycoprotein either with or without adjuvant 
administered at 6 and 4 weeks pre-farrowing. All inoculations were 
intramuscular (IM). Adjuvants were Freund's complete and incomplete 
(Difco Labs, Detroit, Mich.), aluminum hydroxide and a polyamine lipid 
adjuvant. 
Preparation of peripheral lymphocytes Peripheral blood was 
collected from gilts 2 weeks pre-farrowing in preservative-free heparin 
and diluted 1:1 with phosphate-buffered saline (PBS). The lymphocytes 
were then separated from whole blood by centrifugation at 400 x g for 
30 minutes on Ficoll (Pharmacia, Uppsala, Sweden) hypaque (Sigma Chemical 
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St. Louis, Mo.; specific gravity 1.078) according to Boyum (1968). 
The cells were collected and washed several times in RPMI 1640 (Gibco, 
Grand Island, N.Y.) plus 20% (v/v) newborn calf serum (NCS) (Flow 
Labs, McLean, Virginia). Nonimmune lymphocytes were derived from an 
8 month-old barrow which served as a control pig. 
Lymphocyte viability was determined using the trypan blue exclusion 
principle and viability was always%> 90%. Lymphocytes were then counted 
and placed into the transformation assay. 
Lymphocyte assay The proliferation assay used was a modification 
of Valentine's (1971) procedure. Briefly, a lymphocyte suspension 
containing 5x10^  cells/0.1 ml was dispensed into the wells of a 96-well 
tissue culture plate. A serial dilution of the glycoprotein was made 
in RPMI 1640 plus 20% (v/v) NCS and each dilution was dispensed in 
0.1 ml amounts to the wells. All cultures were set up in either 
triplicate or quadruplicate. Controls for the transformation of 
lymphocytes consisted of replacing antigen with PHA and Con A. In a 
preliminary experiment the optimal concentrations of PHA and Con A • 
necessary to stimulate porcine lymphocyte blastogenesis were determined. 
Lymphocyte cultures were incubated for 5 days at Sfc in a humid 5% 
3 COg atmosphere. During the last 5 hrs of incubation 0.1 ml of ( H) 
thymidine (New England Nuclear, Boston, Mass.; specific activity 6.7 
Ci/m mol), prepared in RPMI 1640 plus 20% NCS, was added to each well. 
After incubation, the cultures were frozen, thawed and subsequently 
harvested on glass filters in a Microharvester (Bellco Glass Inc., 
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Vineland, N.J.) cell collector. Five ml of a scintillation cocktail 
consisting of toluene and liquiflour (New England Nuclear, Boston, 
Mass.) were added. The glass filter discs were then put into scintilla-
3 tion vials and the quantity of ( H) thymidine incorporated into the DNÂ 
of the lymphocytes was determined using a Beckman (Beckman Instruments, 
Fullerton, Calif.) LS-230 scintillation counter. 
Stimulation Index 
The stimulation index (SI) of cultures was calculated as follows: 
CPM of experimental _ 
CPM of control 
Goat anti-porcine thymocyte serum Thymocytes were obtained 
from porcine thymus according to James' (1973) method. Briefly, the 
thymus was minced in Gey's medium containing RNase. It was then filtered 
through sterile gauze and a sterile glass bead column in order to 
eliminate epithelial cells. Thymocytes were then diluted to 10^ -10^  
cells/ml in PBS and 7 ml were injected, with Freund's complete adjuvant, 
(Difco Labs., Detroit, Mich.) into a goat. 
The same number of cells was administered with Freund's incomplete 
adjuvant (Difco Labs., Detroit, Mich.) 2 and 4 weeks later. Two weeks 
after the last injection the goat was bled, and the serum was collected 
and absorbed twice with porcine bone marrow cells. The anti-porcine 
thymocyte serum was titered using a cytotoxicity assay and had a titer 
of 1:1000 (Shimizu and Shimizu, 1979a). 
Rosette formation Peripheral lymphocytes were collected as 
previously described. Rosette formation was performed according to 
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Brown et al. (1975) and Baxley et al. (1973). Briefly 2.5x10^ /ml 
8 lymphocytes and 7.0x10 /ml sheep red blood cells (SRBC) were incubated 
at 37°C for 20 minutes in a humid 5% CO^  atmosphere. The cell suspension 
was centrifuged for 5 minuted at 200 x g and kept in melting ice for 
60 minutes, then gently resuspended. Dextran T-70 (Pharmacia, Uppsala, 
Sweden) was used in the medium at a 6% (s/v) concentration. 
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RESULTS 
Blastogenesls occurred when sensitized lymphocytes were exposed 
to antigen (Fig. 2-4). When cells were obtained from a gilt which had 
received antigen with Freund's complete adjuvant a good blastogenic 
response to the glycoprotein was detected in vitro (Fig. 2). Similar 
results were seen with lymphocytes from a gilt receiving vaccine in which 
a polyamine lipid adjuvant was incorporated (Fig. 3). A moderate 
amount of iji vitro stimulation was seen with cells from a pig following 
immunization with just the glycoprotein without any adjuvant (Fig. A). 
Lymphocytes from a control pig which was given phosphate-buffered 
saline (PBS) did not respond to the glycoprotein component vitro 
but did, however, respond to the mitogen conconavalin A (Fig. 5). 
The vitro response achieved with cells using Reheis' aluminum 
hydroxide adjuvant is questionable at this point (Fig. 6). Although 
the response suggests poor stimulation, more data need to be collected 
to make an objective evaluation. The antibody titers in serum and 
colostrum based upon a virus neutralization assay correlated very well 
with the stimulation of lymphocytes from the same animals (Table 1). 
The blastogenic responses to both viral antigen and the T-cell 
specific mitogens Con A and PHA were diminished in the presence of 
anti-porcine thymocyte serum and complement (Fig. 7). 
This anti-porcine thymocyte serum inhibited all T-cell rosetting 
with sheep red blood cells (SRBC) (Fig. 8,9). 
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Table 1. TGE titers from gilts immunized with subunit glycoprotein 
and various adjuvants 
* 
Titers 
Colostrum Serum 
Glycoprotein and 
polyamine lipid adjuvant 1:3 K 1:625 
Glycoprotein and 
aluminum hydroxide adjuvant 1:625 1:625 
Glycoprotein and 
Freund's complete adjuvant 1:700 1:231 
Glycoprotein only 1:3 K 1:25 
Control (PBS) 1:5 1:5 
* 
titers determined by plaque reduction assay - virus neutralization. 
In vitro culturing of glycoprotein from the Miller strain with 
lymphocytes from a pig immunized with Illinois strain glycoprotein 
resulted in lymphocyte transformation (Fig. 10). 
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DISCUSSION 
A cellular immune response occurs following a TGE viral infection 
(Frederick and Bohl, 1976; Woods, 1977; Shimizu and Shimizu, 1979a, 
1979b). This response is both local and systemic when pigs are 
exposed orally to the virulent TGE virus (Shimizu and Shimizu, 1979a, 
1979b). This response strongly suggests a mechanism for recovery from 
primary viral infection and protection against reinfection. It is 
quite possible that CMI has a vital role in the recovery of pigs 
from TGE infection through the cytotoxic effect of sensitized lympho­
cytes on newly infected epithelial tissue in the small intestine 
(Shimizu and Shimizu, 1979a). 
Proliferative jji vitro responses of lymphocytes to specific 
antigens have been considered to be an vitro correlate of CMI 
(Valentine, 1971). It has been demonstrated that the lymphocyte 
reactivity to viral antigen in pigs orally exposed to TGE virus was 
largely T-lymphocyte-dependent (Shimizu and Shimizu, 1979a). It may 
be quite possible to regard the lymphocyte proliferative response as 
an ^  vitro correlate of CMI in pigs vaccinated with the subviral 
glycoprotein. 
In this study we attempted to demonstrate a cellular response to 
a subviral glycoprotein. This was done in order to demonstrate an 
in vitro correlation between systemic lymphocyte proliferation and 
possible CMI established following immunization with the subunit 
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glycoprotein. 
Blast transformation of peripheral immune lymphocytes was 
demonstrated. This i^ vitro blastogenesis was observed with 
lymphocytes from animals vaccinated with antigen given both with 
and without adjuvant. It has been demonstrated that adjuvants 
greatly enhance the humoral response to the glycoprotein. Adjuvants 
do play an important role in the processing and presentation of 
antigens to the various cells of the immune system. However, until 
more data are obtained on the adjuvants which were used it can only 
be suggested that the degree of response is dependent upon the type 
of adjuvant. 
Wells et al. (1977) working with cows reported on the depression 
in responsiveness of lymphocytes to PHA in the immediate post-parturient 
period. They found that cells from newly calved cows respond less to 
PHA than do nonpregnant cows. Birkeland and Kristoffersen (1977) 
studying lymphocytes from pregnant women found no pregnancy related 
changes to PHA, PWM or MLC. However, they did notice a significant 
depression to PPD in the second half of pregnancy. They also felt 
that variations in the results from various research groups working 
on the effects of pregnancy to the immune response were caused by: 
a) differences in test systems and b) tests carried out as 'single 
determinations'. 
Although it was not our primary intention to analyze cellular 
immune responses in relation to pregnancy, our experiments indicate 
that in the porcine system, at least at two weeks pre-parturition, 
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there is no significant depression of lymphocyte activation. 
Experiments were carried out to clarify the effects of anti-porcine 
thymocyte serum and guinea pig complement on the lymphocyte proliferation 
response to the subviral unit. The elimination of T-cells by the 
3 
anti-porcine thymocyte serum led to a distinct lack of ( H) thymidine 
uptake by lymphocytes. Whether the T-cell was acting in this situation 
as the main effector cell or primarily as a helper cell remains to be 
established. However, at this point it seems as though at least part 
of the effector lymphocytes may belong to the population of porcine 
T-lymphocytes. The same anti-porcine thymocyte serum which depressed 
T-lymphocyte proliferation also inhibited T-cell rosette formation. 
Shimizu et al. (1976) clearly demonstrated that the erythrocyte rosette-
forming cell of the pig is the T-lymphocyte. 
Antibody titers of serum and colostrum from these same animals 
correlated well with the degree of response demonstrated by the lympho­
cytes. The titers were determined using a virus neutralization plaque 
reduction assay and the titers were higher from those animals that 
demonstrated a greater lymphocyte response. Colostral and milk antibody 
are of utmost importance in protecting the piglet against TGE virus 
because anti-TGE antibody in the lumen of the intestine neutralizes 
the pathogen. Garwes et al. (1975, 1979) states that by parenteral 
administration of inactivated virus circulating antibody of the IgG 
class is elicited and little or no specific IgA is found. They have 
demonstrated that inactivated purified TGE virus is capable of Inducing 
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a neutralizing antibody response in pigs. They also suggest that a 
viral structural element is the antigen responsible for stimulating 
the neutralizing antibody. 
MacNaughton (1980) suggested that the difference that is found 
in protein and glycoprotein profiles of coronaviruses is somewhat due 
to their condition of preparation. This includes the conditions under 
which the virus is replicated. Although the Miller strain is a cell 
culture adapted strain and was propagated in cell culture and the more 
virulent Illinois strain was harvested from piglet gut, there seems to 
be a shared antigenicity between the glycoprotein immunogen isolated 
from the two viruses. This is demonstrated by the fact that the 
glycoprotein of the Miller strain stimulated the lymphocytes sensitized 
to the glycoprotein of the Illinois strain. The significance of this 
is that the glycoprotein subunit isolated from attenuated TGE virus may 
be used effectively to immunize against virulent virus. Further 
investigation of the antigenic nature of the two glycoproteins is 
underway. 
Fig. 1. Preparation of glycoprotein subunit. 
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CENTRIFUQATION 
5000 X g 30 min 
1 
VIRUS PRECIPITATION 
7.0% PEG 6000 
2.3% NaCI 
4«C 1.5-2.5 hrs 
i 
CENTRIFUQATION 
9500 X g 30 min 
Disperse PPT EMEM pH-7.6 
i 
RATE ZONAL CENTRIFUQATION 
Discontinuous Sucrose Gradient 
100,000 xg 1.5 hrs 
1.122 gm/mi-VIRUS 
SONICATION 
DIalyze (TRIS - EDTA - Saline) 
i 
ISOPYCNIC CENTRIFUQATION 
Contlnuous^ucrose Gradient 
260,000 xg  ^ 18-20 hrs 
GEL FILTRATION 
Sephacryl S-200 
Fig. 2. Lymphocyte response from gilt immunized with Illinois 
glycoprotein subunit and Freund's complete adjuvant. 
Stimulation index represents the range of the mean 
of assays run in quadruplicates. 
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1 Immune cells 
I Non*Immune ceils 
1 i 1 Cônirbi» 33 ~ 3.3 .33 .033 .0033 .00033 PHA Con A 
»—Qlyccplrolein Cone, (mq) « 
'Stimulation Index 
Fig. 3. Lymphocyte response from gilt immunized with Illinois 
glycoprotein subunit and polyamine lipid adjuvant. 
Stimulation index represents the range of the mean of 
assays run in quadruplicate. 
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Immune cells 
Non-Immune cells 
Controls 33 3.3 .33 .033 .0033 .00033 Con A 
I Glycoprotein Cone, (mb) 1 
'Stimulation Index 
Fig. 4. Lymphocyte response from gilt immunized with Illinois 
glycoprotein subunit and no adjuvant. Stimulation 
index represents the range of the mean of assays run in 
quadruplicate. 
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Itj Immune cells 
• Non-Immune cells 
Control 33 3.3 . .33 .033 .0033 .00033 Con A 
> Glycoprotein Cone, (fjg) 1 
Stimulation Index 
Fig. 5. Lymphocyte response from gilt treated with PBS. 
Stimulation index represents the range of the mean 
of assays run in quadruplicate. 
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M Control Lymphocytes 
• Control PBS Lymphocytes 
Control u 3.3 .33 .033 .0033 .00033 Con A 
I Glycoprotein Cone. (MS) 1 
Fig. 6. Lymphocyte response from gilt immunized with Illinois 
glycoprotein and Reheis' aluminum hydroxide. 
Stimulation index represents the range of the mean 
of assays run in quadruplicate. 
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Control 33 3.3 .33 .033 .0033 .00033 COn A 
I Glycoprotein Cone, lug) 1 
'stimulation Index 
Fig. 7. Lymphocyte response from a gilt treated with Freund's 
complete adjuvant and glycoprotein after treatment with 
anti-porcine thymocyte serum and guinea-pig complement. 
Stimulation index represents the range of the mean of 
assays run in quadruplicate. 
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Controls 33 3.3 .33 .033 .0033 .00033 .00003 PHA Con A 
I Glycoprotein Cone, (jig) 
'stimulation index 
Fig. 8. Rosette formation with porcine T-lymphocytes and sheep 
red blood cells (SRBCs). 
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Fig. 9. Inhibition of rosette formation of porcine T-lymphocytes 
with sheep red blood cells (SRBCs) using anti-porcine 
thymocyte serum. 
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Fig. 10. Lymphocyte response to Miller glycoprotein subunit after 
primary immunization to Illinois glycoprotein subunit. 
Stimulation index represents the range of the mean of 
assays run in quadruplicate. 
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SUMMARY 
A glycoprotein subunit isolated from the tissue culture-adapted 
Miller strain of transmissible gastroenteritis virus (TGEV) stimulated 
lymphocytes i^ vitro which had been previously sensitized i^ vivo to 
the glycoprotein from the virulent Illinois strain of TGEV. 
Comparison of the glycoprotein isolated from both strains of 
TGEV by immunodiffusion, rocket electrophoresis, and cross-immuno-
electrophoresis showed the two antigens to be identical. A minor 
antigenic contaminant was associated with the glycoprotein. Adsorption 
by ammonium sulfate - fractionated hyperimmune serum demonstrated that 
the antigens were derived from the virion and not the host. 
An apparent molecular weight of 67,000 was calculated for the 
glycoprotein following sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). When it was subjected to polyacrylamide 
gel isoelectric focusing (PAG-IEF), the subunit was shown to have an 
isoelectric point (P.I.) of 3.86. 
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INTRODUCTION 
The first viral subunit vaccine was introduced by Warburton in 
1969. It was known as the influenza "split vaccine" because it con­
tained only hemagglutinin and neuraminidase antigens. The febrile 
response characteristic of immunizations with the whole virus vaccine 
did not occur with this subunit. Furthermore, Rubin and Tint (1975), 
working with an influenza subunit vaccine in clinical trials, revealed 
that the immune responses of subunit vaccinates were equal to if not 
better than those achieved with whole virus vaccines. Gross et al. 
(1977) however, found the immunogenicity of the subunit to be generally 
lower although they agreed the subunit vaccines are far safer than are 
live or inactivated virus vaccines. 
Immunogenicity of viral subunit vaccines is dependent upon the 
integral membrane proteins that are associated with the hydrophobic 
core of the phospholipid bilayer in membranes (Morein et al. 1978). It 
is most important in preparing the vaccines to utilize methods that 
retain the native antigenic conformational characteristics of these 
components. The immunogenicity of subunit vaccines also is related to 
the structural form of proteins present in the vaccine. Jennings et al. 
(1974), Morein et al. (1978) and Schafer and Bolognesi (1977) reported 
that monomeric forms of envelope proteins are not suitable for use in 
subunit vaccines because of a lack of immunogenicity. 
Morein et al. (1978) found that the immunogenic subunits of 
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enveloped viruses are the envelope glycoproteins. These glycoproteins 
were removed selectively from the envelopes of rhabdoviruses by the 
use of nonionic detergents. Kelley et al. (1972) showed that treatment 
of vesicular stomatitis virus with Triton X-100 released glycoprotein 
G which elicited specific serum neutralizing antibodies. Similarly, 
Wiktor et al. (1973) reported that Nonidet P-40 solubilized glycoprotein 
G of rabies virus which induced a serum neutralizing antibody response 
that protected animals against a lethal challenge with virulent virus. 
Subunit vaccines for nonenveloped viruses have not been as 
successful as those for enveloped viruses. With the adenoviruses 
Neurath and Rubin (1971) reported that, for protection against infection, 
it was necessary to have antibodies directed towards other antigenic 
sites in addition to neutralizing antibodies directed towards the 
pentons and fibers. 
Because of their safety features subunit vaccines are becoming 
popular. These vaccines are especially being considered for the herpes 
virus family because of the unique relationships that exist between the 
host and the virus. These viruses establish persistent and latent 
infections and also present an oncogenic risk to the patient, (Parks 
and Rapp, 1975 and Vernon et al. 1978). Hence, it seems that the most 
reasonable approach to induction of protection against herpes viruses 
is subunit vaccines that are free of viral genetic material. 
Transmissible gastroenteritis (TGE) is a very contagious disease 
which causes severe losses among young swine. Mortality from the 
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infection can run as high as 100%. In surviving swine, the pathogen 
can have detrimental effects on performance, including slow gain of 
weight, runting and poor utilization of feedstuffs. The use of live 
or U.V. -inactivated viruses for immunization seems quite risky. 
Therefore, a subunit vaccine appears to be a useful approach for 
immunoprophylaxis against TGE. 
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MATERIALS AND METHODS 
Procedures 
Virus strains Illinois strain TGE virus was prepared as the 
supernatant fluid from a 10% (w/v) homogenized suspension of infected 
small intestine from 3 to 5 day old piglets. The animals had received 
200 PID^Q of the virus orally and were killed when signs of disease 
became significant but before the pigs were moribund. 
Miller strain TGE virus was prepared using a modification of 
Woods' (1976) procedure. Briefly, McClurkin swine testicle (ST) 
2 
monolayers grown in 175-cm tissue culture flasks were inoculated with 
1.0 ml of a 3 X 10^ PFU suspension of virus. The virus was allowed 
to adsorb for 1 hr at 37°C in a humid, 5% CO^ atmosphere, and then 
50 ml of Eagle's minimal essential medium (EMEM) without serum were 
added and incubation was continued. The virus was harvested 48 hrs 
later, following three cycles of freeze-thawing. 
Purified virus of both strains was prepared by precipitation of 
virus in 7% (w/v) polyethylene glycol (PEG 6000) and 2.6% (w/v) sodium 
chloride at 4°C for 1^^2% hrs. The precipitate was collected by centrif-
ugation at 9500 xg for 30 minutes. The precipitate was then dispersed 
in EMEM and whole virus was collected following rate-zonal centrifu-
gation (Flow Chart, Fig. 1). 
Glycoprotein preparation The virus was disrupted by high 
frequency sound with a Biosonic IV sonic oscillator (VWR Scientific, 
San Francisco, Ca.) and a glycoprotein component was collected following 
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isopycnic ultracentrlfugation and purified by gel filtration through 
Pharmacia's (Uppsala, Sweden) Sephacryl S-200 (Flow Chart, Fig. 1). 
The preparation was checked for live virus. 
Experimental animals One first litter gilt was obtained from 
a specific pathogen-free (SPF) herd. The pig was of Duroc breeding 
and was seronegative for TGE. Immunization consisted of 1 ml of a 
1 mg/ml suspension of TGE viral glycoprotein either with or without 
adjuvant, administered at 6 and 4 weeks pre-farrowing. Freund's complete 
and incomplete were the adjuvants used. All inoculations were intra­
muscular (IM). 
Preparation of peripheral lymphocytes Peripheral blood was 
collected from the gilts 2 weeks pre-farrowing in preservative-free 
heparin and diluted 1:1 with phosphate-buffered saline (PBS). The 
lymphocytes were then separated from whole blood by centrifugation at 
400 s g for 30 minutes on Ficoll (Pharmacia, Uppsala, Sweden)-Hypaque 
(Sigma Chemicals, St. Louis, Mo.) (specific gravity 1:078) according to 
Boyum (1968). The cells were collected from the interface and washed 
several times in RPMI 1640 plus 20% (v/v) newborn calf serum (NCS). 
Lymphocyte viability was determined using the trypan blue exclusion 
principle and viability was always 90%. Lymphocytes were then counted 
and placed into the transformation assay. 
Lymphocyte transformation assay The proliferation assay used 
was a modification of Valentine's procedure (1971b). Briefly, a 
lymphocyte suspension containing 5x10^ cells/0.1 ml was dispensed into 
the wells of a 96-well tissue culture plate. A serial dilution of the 
glycoprotein was made in RPMI 1640 plus 20% (v/v) NCS and each dilution 
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was dispensed in 0.1 ml amounts to the wells. All cultures were set 
up in either triplicate or quadruplicate. Controls for the trans­
formation of lymphocytes consisted of replacing antigen with phyto-
hemagglutinin (PHA) and Concanavalin A (Con A) purchased from Sigma 
Chemicals (St. Louis, Mo.). In a preliminary experiment the optimal 
concentrations of PHA and Con A necessary to stimulate blastogenesis 
of porcine lymphocytes were determined. Lymphocyte cultures were 
incubated for 5 days at 37°C in a humid 5% CO^ atmosphere. During the 
3 last 5 hrs of incubation 0.1 ml of ( H) thymidine (specific activity 
6.7 Ci/m mol; New England Nuclear, Boston, Mass.), prepared in RPMI 1640 
plus 20% NCS, was added to each well. After incubation the cultures were 
frozen and thawed and subsequently harvested on glass filters in a 
Microharvester cell collector (Bellco Glass Inc., Vineland, N.J.). 
Five ml of a scintillation cocktail consisting of toluene and liquiflour 
(New England Nuclear, Boston, Mass.) were added. The glass filter discs 
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were then put into scintillation vials and the quantity of ( H) thymidine 
incorporated into the DNA of the lymphocytes was determined using a 
Beckman LS-230 scintillation counter. 
The stimulation index (SI) of cultures was calculated from the 
data as follows; 
CPM of Experimental _ ^ 
CPM of Control 
Polyacrylamide gel electrophoresis (PAGE) The PAGE procedure 
was performed according to Davis (1964); the standard 7% acrylamide gel 
system with methylene-bis-acrylamide cross-linking was used. The 
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stacking gel was at pH 8.9 and the actual running gel was at pH 9.5. 
Both the upper and lower chambers were filled with a tris (2.5 mM)-
glycine (0.2M) buffer at pH 9.5. The samples were mixed with 40% 
(w/v) sucrose, to increase their densitites, and one drop of 0.005% 
(w/v) bromophenol blue, as the tracking dye. The gels underwent 
electrophoresis at 4°C for 2.5 hrs with the current at 2. mA per tube. 
The gels were then removed, fixed in 7% acetic acid and stained for 
2 hrs In Coomassie brilliant blue R-250 (Eastman Kodak, Rochester, N.Y.) 
and destalned in ethanol-acetlc acid-distilled water (3:1:10) overnight. 
Sodium dodecyl sulfate polyacrylamlde gel electrophoresis (SDS-PAGE) 
This procedure was performed according to Laemmli (1970). The 
samples were treated with 2% (w/v) SDS and 5% (v/v) 2-mercaptoethanol 
and heat-denatured at 100°C for 2 minutes. The upper and lower chambers 
of the electrophoretic apparatus contained a tris -HCl (0.025M), 
glycine (0.2M) buffer with 1% (w/v) SDS. The gels in 12.5 cm tubes were 
then electrophoresed for approximately 3 hrs at 200 volts using a BIO RAD 
Model 500 power supply. Pharmacia low molecular weight range standards 
were electrophoresed along with the samples. The gels were then fixed in 
7% (v/v) acetic acid and staining and destaining was the same as that 
described for PAGE. 
Polyacrylamlde gel isoelectric focusing (PAG-IEF) 
Pharmacia wide pH range (3.5-10.0) ampholyte was used first and 
then a narrow range (3.5-5.0) ampholyte. A stock solution was made by 
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adding 29.3 gm of acrylamide and 0.75 gm of methylene-bis-acrylamide 
to distilled water for a final volume of 100 mis. To 6.3 ml of stock 
solution was added: 1.3 gm of glycerol, 10 ml of distilled water and 
1.25 ml of ampholytes. Riboflavin-5'-phosphate (20 mg/100 ml water) 
and water were added to a final volume of 25 ml. Gel slices from PAGE 
containing the major band were placed on gels and electrophoresed for 
18-20 hrs at 200 volts. The gels were then fixed in 7% (v/v) acetic 
acid and stained and destained according to the procedure described for 
PAGE. One blank gel was also included to determine any nonspecific 
staining. The isolectric point (P.I.) was determined by slicing out the 
band from several gels and collecting the segments in a tube. Deionized 
distilled water was added to immerse the gel segments and the pH of the 
eluants was taken after 24 hrs. 
Periodic acid - Schiff reagent (PAS) 
The samples were handled as in PAGE except for the staining and 
destaining procedure. The procedure of Zacharius and Zell (1969) was 
followed for staining and destaining. Briefly, the gels were immersed 
in 12.5% trichloroacetic acid (TCA) for 30 minutes. Then they were 
rinsed lightly with distilled water and placed in a 1% periodic acid 
solution (prepared in 3% (v/v) acetic acid) for 50 minutes. Next 
the gels were washed overnight in 2.5 liters of distilled water. The 
gels were then immersed in fuchsin-sulfite stain in the dark for 2 hrs. 
After this they were washed for 30 minutes with 3 changes in freshly 
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prepared 0.5% (w/v) metabisulflte. Finally the gels were rinsed and 
destained overnight in distilled water and stored in 7% acetic acid. 
Antisera 
Hyperimmune serum was prepared in four 6 month-old Duroc swine 
which received 3 intramuscular (IM) injections of Illinois TGEV and 
Freund's incomplete adjuvant. The injections were given at 3-week 
intervals. 
Ammonium sulfate fractionation was carried out on the hyperimmune 
serum. Briefly, the pH of 50 ml of a saturated (NH^)2S0^ solution was 
adjusted to 7.8, and the solution was added dropwise with constant 
stirring to 100 ml of serum. At first additions were not made until 
all the precipitate was dissolved but eventually the precipitate persisted. 
At this point the salt solution was added slowly. The suspension was 
stirred continually overnight at 4°C and then centrifuged at room 
temperature at 1400 x g. The precipitate was dissolved in 0.85% saline 
to the original volume of serum. Gamma-globulins were further purified 
by precipitation two more times. The third precipitate was dissolved in 
Tris-glycine buffer to a final volume of 1/2 the original serum sample 
and dialyzed against Tris-glycine buffer pH 8.6 at 4°C with 3 changes 
in 24 hrs. 
Absorption of fractionated serum was accomplished with 3X volume 
of a 10% normal gut slurry at 37°C for 1 hr. The mixture was centrifuged 
at 400 X g for 20 minutes and the serum was collected. 
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Rocket electrophoresis and cross-lmmunoelectrophoresis 
This procedure is a modification of Weeke's (1973) procedure. 
Electrophoresis was conducted on a LKB 2117 Multiphor with the 1KB 2103 
power supply. Approximately 10 mis of a 1% BIO RAD agarose, prepared 
in Tris-Tricine-Triton X-100 buffer, pH 8.6, was poured onto an 84 x 94 mm 
plastic plate (LKB) and was allowed to gel for 15 minutes. The first 
dimension electrophoresis of a 15-20 ul sample of antigen was performed 
by applying 10 v/cm for 120 minutes. For the second dimension, the 
major portion of the agarose on the plate, not containing the electro-
phoresed antigens, was removed and the plate was repoured with the same 
agarose containing 6-8% (v/v) hyperimmune antisera. This time the power 
was set at 1.5 v/cm and electrophoresis was for 18-20 hrs at 10°C. 
Afterwards the gels were dried to a film using a conventional gun-type 
dryer. The gel was then washed twice, for 10 minutes each, in 0.1 N 
NaCl and washed twice, also for 10 minutes each, in distilled water. 
The plates were stained for 10 minutes in Coomassie brilliant blue R-250, 
destained for 10 minutes and dried. 
Immunodiffusion test 
The agarose double diffusion test was performed on 84 x 94 mm LKB 
Multiphor plastic plates. The plates were coated with 10 ml of a 1% 
(w/v) BIO RAD agarose made up in a Tris-tricine-Triton X-100 buffer. 
Wells were punched using the conventional hexagonal pattern and reagents 
were added. The test was read after 24 hrs of incubation in a moist 
chamber. 
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Buffers 
Tris-Tricine-Triton X-100 buffer consisted of 17.2 g Tricine, 
39.2 g Tris, 40 ml Triton X-100, 0.424 g calcium lactate, and 0.800 g 
sodium azide, Q.s. to 4 liters with distilled water and adjusted to 
pH 8.6. Tris-Glycine buffer consisted of 0.0038 M-TriS and 0.01 M-
glycine adjusted to pH 8.6. 
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RESULTS 
The glycoprotein subunit that was isolated from the Miller strain 
TGE virus stimulated lymphocytes i^ vitro that were originally sensitized 
in vivo to the Illinois glycoprotein Figure 2. When compared using 
immunodiffusion the preparations of Miller and the Illinois glycoproteins 
revealed two precipitating lines of identity Figure 3. Rocket electro­
phoresis of the purified samples from either strain showed one very 
distinct peak of precipitation Figure 4. When electrophoresed in close 
proximity the Illinois and Miller purified samples had peaks which 
fused together Figure 5. Rocket electrophoresis with hyperimmune serum 
that had been adsorbed with host-material revealed rockets to glyco­
proteins from both strains of TGEV Figure 6. With cross-immunoelectro-
phoresis both glycoprotein samples had two peaks with similar shape 
and migration pattern Figure 7. The two peaks seemed to be of similar 
antigenic composition. 
Electrophoretic analysis of the preparation, of Illinois viral 
subunit in polyacrylamide gels revealed one major band and three minor 
bands after having been stained with Coomassie brilliant blue Figure 8. 
Since it stained with PAS, the major band was determined to be 
glycosylated Figure 8. The major band was then isolated from the gels 
and subjected to treatment by 2-mercaptoethanol and SDS-PAGE for 
determination of molecular weight. When compared with Pharmacia's low 
molecular weight standards, a single band appeared in the vicinity of 
bovine serum albumin which is approximately 67,000 Figure 9. This 
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same major band was Isoelectrically focused using Pharmacia's wide 
range ampholyte (pH 3.5-10.0) and narrow range (pH 3.5-5.0) ampholyte 
Figure 10. The glycoprotein appeared to be extremely acidic with a 
PI of 3.86. 
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DISCUSSION 
A glycoprotein viral 'subunit isolated from TGE coronavirus 
stimulated dji vitro lymphocyte transformation of immune peripheral 
lymphocytes from a vaccinated gilt. Blast transformation has been 
shown to be an vitro correlate for cell mediated immunity (CMI) 
(Valentine, 1971a). Shimizu and Shimizu (1979) demonstrated cytotoxic 
lymphocytes to TGEV-infected target cells from pigs orally exposed 
to the pathogen. They also used a lymphocyte proliferation assay to 
detect lymphocytes sensitized to intact TGEV and also to a TGE viral 
antigen. Woods (1976), using a leukocyte aggregation assay, demonstrated 
CMI to infection with TGEV. This assay was based upon the presence of 
long term recirculating memory lymphocytes and was directed toward 
evaluation of the CMI concept. 
An antigenic similarity between the glycoprotein derived from the 
Miller and from the Illinois strain of TGEV was evident when lymphocytes 
sensitized to the Illinois glycoprotein gave good Iji vitro blast-trans­
formation when exposed to the heterologous glycoprotein. Hence, further 
antigenic investigations were necessary to confirm these results. 
Using immunodiffusion it was discovered that preparations of 
Illinois and Miller strains formed two precipitating lines of identity. 
This indicates that there were two similar antigenic components in 
each preparation. 
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With rocket electrophoresis it was also demonstrated that there 
were some identical or partially identical components in the two 
preparations of glycoprotein. Fusion of rockets occurred. One very 
sharply defined component was revealed in each preparation. The 
antigenic components definitely were derived from the virion and not 
the host because serum adsorbed with host material produced rockets 
to each glycoprotein sample. 
In cross-immunoelectrophoresis of the glycoprotein from the two 
strains of TGEV, two peaks one sharply defined and the other not as 
sharply defined, migrated similarly and had the same shape. 
Some researchers using different techniques have demonstrated 
subunit components from coronaviruses with similar molecular weights to 
our glycoprotein. Hajer and Storz (1979) found seven distinct poly­
peptide bands after electrophoresis of SDS-solubilized bovine coronavirus 
LY-138 virions in polyacrylamide gels. Four of these bands were positive 
for the periodic acid-Schiff test, which indicated that they were 
glycoprotein in nature. One of the polypeptides they isolated had an 
approximate molecular weight of 70,000. Sturman and Holmes (1977) 
working with the murine coronavirus A-59 demonstrated six major poly­
peptides under standard conditions of SDS-PAGE. However, when the 
proteins were solubilized at either 25° or 37°C only four size classes 
were observed. They found a glycoprotein subunit with an apparent 
molecular weight of 60,000. Siddell et al. (1980) demonstrated that 
the host cells infected with murine coronavirus JHM no longer synthesized 
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host cell proteins but rather synthesized virion structural proteins 
P60 and P23. From the infected cells they extracted a polyadenylated 
RNA which was used for the iji vitro synthesis of both a 60,000 and a 
23,000 MW polypeptide. Wege et al. (1979) showed that the coronavirus 
JHM contains six polypeptides in SDS-PAGE. One of these polypeptides is 
nonglycosylated and has a molecular weight of 60,800. Hierholzer 
et al. (1972) demonstrated a glycosylated subunit of molecular weight 
60,000 from the human coronavirus OC43. 
Garwes and Pocock (1975) feel that the molecular weight assigned 
to the TGE virion polypeptides cannot be considered as certain since the 
presence of carbohydrate on polypeptides may affect the apparent 
molecular weight determined by relative mobility through polyacrylamide 
gel. 
The glycoprotein subunit demonstrates a great deal of potential 
as an immunogen. It has immune response stimulating qualities which 
have been revealed in lymphocyte transformation assays. It is a subunit 
viral component which is extremely safe for immunizations and the fact 
that it is shared by different strains gives support to its efficacy as 
a universal immunogen for TGE. 
Fig. 1. Preparation of glycoprotein subunit. 
75 
CENTRIFUGATION 
5000 X g 30 min 
t 
VIRUS PRECIPITATION 
7.0% PEG 6000 
2.3% NaCI 
4«C 1.5-2.5 hrs 
t 
CENTRIFUGATION 
9500 X g 30 min 
Disperse PPT EMEM pH-7.6 
i 
RATE ZONAL CENTRIFUGATION 
Discontinuous Sucrose Gradient 
100,000 xg 1.5 hrs 
1.122 gm/ml-VIRUS 
I 
SONICATION 
Dialyze (TRIS - EDTA - Saline) 
t 
ISOPYCNIC CENTRIFUGATION 
Continuous Sucrose Gradient 
260,000 xg ^ 18-20 hrs 
GEL FILTRATION 
Sephacryl S-200 
Fig. 2. Lymphocyte response to Miller glycoprotein subunit after 
primary immunization to Illinois Glycoprotein Subunit, 
Stimulation index represents the range of the mean of 
assays run in quadruplicate. 
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I Immune cells 
I Non-Immune cells 
].} .33 .033 .0033 .00033 .00003 
-Glycoprotein Cone, (pg) ' 
Fig. 3. Immunodiffusion of Illinois and Miller virus glycoprotein 
preparations. A - fractionated-hyperimmune serum, 
B - crude preparation of Illinois glycoprotein (before 
gel-filtration), C - purified preparation of Miller 
glycoprotein (after gel-filtration), D - purified 
preparation of Illinois glycoprotein. 
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c; 
Fig. 4. Rocket electrophoresis of Illinois and Miller glycoprotein 
preparation. CI = crude Illinois, PI = purified Illinois, 
PM = purified Miller. 
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Fig. 5. Fused rocket electrophoresis of different Illinois and 
Miller virus glycoprotein. CI = crude Illinois, PI = purified 
Illinois, PM = purified Miller. 
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Ci Pi Cl PM 
Fig. 6. Rocket electrophoresis of Illinois and Miller virus 
glycoprotein preparations with adsorbed hyperimmune 
serum. PI = purified Illinois, PM = purified Miller. 
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Fig, 7. Cross-immunoelectrophoresis of Illinois and Miller virus 
glycoprotein preparations. I = Illinois, M = Miller. 

Fig. 8. Polyacrylamide Gel Electrophoresis (PAGE) of Illinois 
glycoprotein. Gel on the left stained in Coomassie 
brilliant blue R-250. Gel on the right stained in PAS. 
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Fig. 9. Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE). Gel on the left Illinois glycoprotein. Gel 
on the right Pharmacia's low-molecular weight standards. 
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Fig. 10. Polyacrylamide Gel Isoelectric Focusing (PAG-IEF). 
Gel on left Pharmacia's narrow-range ampholyte. Gel 
on the right Pharmacias wide-range ampholyte. 
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PART III. IN VITRO PROLIFERATIVE LYMPHOCYTE RESPONSE TO A TGE 
VIRAL SUBUNIT GLYCOPROTEIN WITH LYMPHOCYTES FROM 
VARIOUS ANATOMICAL SITES 
This manuscript has been submitted to the Canadian Journal of 
Microbiology. 
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SIMIARY 
Lymphocytes from pigs vaccinated with a TGE viral subunit 
glycoprotein underwent vitro transformation when exposed to the 
subunit component. The lymphocytes for the blast transformation 
assay were isolated from peripheral blood, mesenteric lymph nodes, 
spleen and Peyer's patches. The greatest amount of transformation 
occurred with those from the Peyer's patches, whereas little if 
any stimulation was observed with lymphocytes isolated from the 
spleen. Peripheral blood and mesenteric lymphocytes showed approx­
imately the same amount of transformation. 
Lymphocytic reactivity to the viral antigen and to the mitogen 
Con A was depressed following treatment of the cells with anti-porcine 
thymocyte serum and guinea-pig complement. 
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INTRODUCTION 
Transmissible gastroenteritis (TGE) of pigs is a highly contagious 
viral disease characterized by severe diarrhea and vomiting. Among 
pigs that are less than 2 weeks old, mortality reaches as high as 100% 
in some outbreaks. Since TGE is an enteric disease, serum antibody 
does not provide protection from the pathogen but lactogenic immunity 
does protect suckling piglets. 
It has been known that pigs which have recovered from a primary 
infection with TGE virus (TGEV) resist subsequent challenge, at least 
for a limited time. A possible mechanism for active immunity is local 
cell-mediated immunity (CMI) in the small intestine. 
Chu et al. (1979) studied the number and distribution of lymphocytes 
in the small intestine of immunocompetent 8-week-old swine during a 
TGEV infection. They discovered that there was no difference between 
controls and TGEV-infected pigs in numbers of interepithelial lymphocytes 
(lEL) at 12 and 18 hrs post-inoculation (PI). However, at 24 hr PI 
a significant decrease occurred in the number of IEL in the duodenum 
and anterior jejunum of infected animals and an increased number 
appeared at the nuclear level. Because of the large number of 
organelles in the lymphocytes, they concluded that most of the cells 
were in a very active state. 
Shimizu and Shimizu (1979a) have demonstrated cell-mediated 
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immunity (Cîtl) in the small intestine after oral inoculation with 
TGEV virus. An in vitro proliferative response to viral antigen 
occurred on PI day (PID) 7 with lymphocytes isolated from peripheral 
blood (PB), spleen (SPLN), Peyer's patches (PP) and mesenteric lymph 
nodes (MLN). The proliferative activity increased and reached a 
maximum on PID 10 to 14. Peyer's patches and MLN contained cells 
which were reactive for at least 110 days PI, whereas, SPLN and PB 
cells were found to have only transient proliferative reactivity. 
Antigen-reactive cells were not detected in SPLN or PB after PID 20 to 
30. 
In another study by Shimizu and Shimizu (1979b) lymphocytes 
isolated from PB, SPLN, PP, and MLN were cytotoxic to virus-infected 
target cells. Cytotoxic lymphocytes appeared on PID 7 and increased to 
reach a maximum on day 21. Unlike proliferation, lymphocytic cytotoxi­
city was greater in lymphocytes from the PB and SPLN than in those of 
PP and MLN after PID 14. In both experiments lymphocytic activity was 
depressed by anti-porcine thymocyte serum and complement. 
Frederick and Bohl (1976) used the production of macrophage 
migration inhibition factor (MIF) by lymphocytes as an indication 
of CMI to TGE virus in pigs. After oral inoculation of swine with TGE 
virus, more MIF was produced by lymphocytes of the lamina propria (LP) 
than by the SPLN lymphocytes. However, following subcutaneous inoculations 
of pigs the SPLN lymphocytes produced more MIF than did the LP lymphocytes. 
In the present study lymphocytes isolated from PB, PP, SPLN, and 
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MLN were examined to determine the CMI achieved in swine following 
immunizations with a TGEV glycoprotein subunit. 
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MATERIALS AND METHODS 
Procedures 
Glycoprotein preparation Illinois strain TGEV was prepared 
as the supernatant fluid from a 10% (w/v) homogenized suspension of 
infected small intestine from 3 to 5 day old piglets. The animals had 
received 200 PID^g of the virus orally and were killed when signs of 
disease became significant but before the pigs were moribund. 
Purified virus was prepared by precipitation of virus in 7% (w/v) 
polyethylene glycol (PEG 6000) and 2.6% (w/v) sodium chloride at 4^ 
for 1^ 5-2^ 5 hrs. The precipitate was collected by centrifugation at 
9500 xg for 30 minutes. The precipitate was then dispersed in Eagle's 
minimal essential medium (EMEM) and whole virus was collected following 
rate-zonal centrifugation (Flow Chart, Fig. 1). 
The virus was disrupted by high frequency sound with a Biosonic IV 
sonic oscillator (VWR Scientific, San Francisco, Ca.) and a glycoprotein 
component was collected following isopycnic ultracentrifugation and 
purified by gel filtration through Pharmacia's (Uppsala, Sweden) 
Sephacryl S-200 (Flow Chart, Fig. 1). The preparation was checked for 
the presence of virus and was negative. 
Experimental animals Six 7 month-old barrows were obtained from 
a specified pathogen-free (SPF) herd. The pigs were of Yorkshire 
breeding. Immunization consisted of 1 ml of a 1 mg/ml suspension of 
TGEV glycoprotein with a polyamine lipid adjuvant, administered as 
3 injections at 2 week intervals. All inoculations were intramuscular 
(IM). The animals were seronegative for TGE. 
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Lymphocyte transformation assay The proliferation assay used 
was a modification of Valentine's (1971a) procedure. Briefly, 0.1 ml 
of a lymphocyte suspension (5x10^  cells) was dispensed into each well 
of a 96-well tissue culture plate. A serial dilution of the glycoprotein 
was made in RPMI 1640 plus 20% (v/v) newborn calf serum (NCS) (Flow 
Labs, McLean, Va.) and each dilution was dispensed in 0.1 ml amounts 
to the wells. All cultures were set up in either triplicate or quad­
ruplicate. Controls for the transformation of lymphocytes consisted 
of replacing antigen with Concanavalin A (Con A) purchased from Sigma 
Chemicals (St. Louis, Mo.). In a preliminary experiment the optimal 
concentration of Con A necessary to stimulate blastogenesis of porcine 
lymphocytes was determined. Lymphocyte cultures were incubated for 
5 days at 37°C in a humid 5% CO^  atmosphere. During the last 5 hrs 
3 
of incubation 0.1 ml of ( H) thymidine (specific activity 6.7 Ci/m mol; 
New England Nuclear, Boston, Mass.), prepared in RPMI 1640 plus 20% NCS, 
was added to each well. After incubation, the cultures were frozen and 
thawed and subsequently harvested on glass filters in a Microharvester 
cell collector (Bellco Glass Inc., Vineland, N.J.). Five ml of a 
scintillation cocktail consisting of toluene and liquiflour (New England 
Nuclear, Boston, Mass.) were added. The glass filter discs were then 
3 put into scintillation vials and the quantity of ( H) thymidine in­
corporated into the DNA of the lymphocytes was determined using a 
Beckman LS-230 scintillation counter. 
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The stimulation index (SI) of cultures was calculated from the 
data as follows: 
CPM of Experimental 
CPM of Control 
Preparation of peripheral lymphocytes Peripheral blood was 
collected in preservative-free heparin from the pigs and diluted 1:1 
with phosphate-buffered saline (PBS). The lymphocytes then were 
separated from whole blood by centrifugation at 400 x g for 30 minutes 
on Ficoll-Hypaque (specific gravity 1.078) according to Boyum (1968). 
The cells were collected from the interface and washed several times in 
RPMI 1640 plus 20% (v/v) (NCS). 
Lymphocyte viability was determined using the trypan blue exclusion 
principle and viability was always >90%. Lymphocytes were then counted 
and placed into the transformation assay. 
Preparation of tissue lymphocytes Lymphocytes from tissues were 
isolated according to a modification of Ford and Hunt (1973) procedure. 
Briefly, tissues were removed aseptically from the animals and were 
immersed immediately into RPMI 1640 medium supplemented with antibiotics 
and 15% fetal bovine serum. Under a laminar flow hood the tissues were 
trimmed of fat and mesentery. They were then teased apart in sterile 
glass petri-plates containing RPMI 1640 medium. Sterile forceps and 
19 gauge needles were used to tease the tissues. The tissue suspension 
were filtered through sterile gauze and washed 3X in RPMI 1640 medium, 
being centrifuged each time at 200 xg for 20 minutes. The lymphocytes 
105 
then were counted in a hemacytometer and diluted to 5 x 10^  cells/ml 
in RMPI 1640 medium. 
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RESULTS 
The proliferation data were analyzed according to the T-distribution 
test. Peripheral blood lymphocytes were compared to lymphocytes 
isolated from the mesenteric lymph nodes, spleen and Peyer's patches. 
The results were statistically significant at the P=0.001 level. A 
comparison was also made between mesenteric lymph node lymphocytes and 
lymphocytes isolated from either Peyer's patches or the spleen. The 
differences shown here were also significant at P=0.001. And lastly 
when lymphocytes from Peyer's patches were compared to spleen lympho­
cytes, a significant difference in proliferation was noted. Therefore, 
statistical differences exist between lymphocytes from various anatomical 
sites when stimulated i^  vitro using a TGE subunit. Table 1. 
Incubation of the sensitized lymphocytes with anti-porcine thymocyte 
serum prevented stimulation by either the TGE subunit or the T-cell 
mitogen Con A, Figure 2. 
Table 1. Statistical evaluation of lymphocyte proliferation data 
Tissues Compared T-value Degrees of Freedom 
PBL-MLN 3.57 38 
PBL-Spln 15.79 38 
PBL-PP 7.55 38 
PP-MLN 3.15 38 
PP-Spln 16.81 38 
MLN-Spln 12.61 38 
MLN - Mesenteric lymph node lymphocytes. 
PBL - Peripheral blood lymphocytes. 
Spin - Spleen lymphocytes. 
PP - Peyer's patches lymphocytes. 
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DISCUSSION 
Valentine (1971b) reported that the itt vitro proliferative response 
of lymphocytes to specific antigens is one of the jbn vitro correlates 
of CMI. The transformation and proliferation of lymphocytes upon 
stimulation with antigen vitro have been found to correlate with the 
presence of delayed type hypersensitivity in the cell donor (Mills 1966; 
Oppenheim et al. 1967; Zweiman et al. 1966). In vitro experiments enable 
measured quantities of lymphocytes from select populations to be exposed 
directly to known amounts of antigen in an isolated and controlled 
environment. 
In our study antigen-reactive cells were identified in all tissues 
tested except for the SPLN. The failure to find sensitive cells in 
the SPLN could possibly be a result of bad timing because Shimizu and 
Shimizu (1979a) reported that the reactivity of cells from both the PB 
and SPLN was transient. Our study did indicate that the gut-associated 
lymphoid tissues (GALT) did contain sensitized lymphocytes. The same 
researchers showed a persistence in reactivity of cells from the GALT 
and thought that perhaps it was attributed to the establishment of a 
carrier state in pigs infected with TGEV. It is believed that in the 
early stages of infection, a portion of TGEV antigen may enter the 
circulation via the gut and stimulate the other lymphoid tissues. 
This study as well as that done by Shimizu and Shimizu (1979a) 
suggests that the T-lymphocyte dependent antigen from TGEV specifically 
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stimulates lymphocytes in the PP and MLN. However, efferent trafficking 
of T-lymphocytes from Peyer's patches is not yet known. It was, however, 
suggested by Frederick and Bohl (1976) that T cells may migrate from 
the intestinal lamina propria (LP) to systemic sites. This would thus 
serve as a source of T-lymphocytes for distribution to the peripheral 
system. They noted that B-lymphocytes migrated from the LP to peripheral 
sites, hence, why not T-lymphocytes as well (Craig and Cebra, 1971). 
Anti-porcine thymocyte serum depressed the lymphocytic activity 
from the MLN, PB and PP. Shimizu and Shimizu (1979a) reported results 
which indicated that the cellular reactivity to viral antigens in pigs 
which were exposed orally to TGEV was largely dependent on T-lymphocytes. 
It is quite possible then to relate the lymphocytic proliferative assay 
as one of the iji vitro correlates of CMI in pigs which have been vaccinated 
with a TGEV subunit. 
This study, along with the previous studies (Shimizu and Shimizu 
1979a,b; Frederick and Bohl 1976), demonstrates the presence of CMI in 
the GALT following either immunization or infection with TGEV. For the 
majority of enteric diseases where serum antibody is of little benefit, 
local active immunity is essential. The GALT (PP and MLN) is extremely 
important for cellular as well as secretory antibody responses. Local 
CMI has two functions on the gut. Firstly, it aids in recovery from the 
disease and secondly it provides protection against reinfection. 
Fig. 1. Preparation of glycoprotein subunit. 
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GENERAL DISCUSSION AND CONCLUSION 
As a consequence of a great number of Investigations into 
immunity to viral infections it has been established that in some 
of the infections cellular immunity but not humoral immunity is 
protective. However, only a few reports have been published on the 
mechanism of resistance to viral enteric diseases (Frederick and 
Bohl 1976, Woods 1977). 
In their studies of transmissible gastroenteritis (TGE) of swine, 
Frederick and Bohl (1976) demonstrated the production of macrophage 
migration-inhibition factor (MIF) by sensitized lymphocytes isolated 
from the spleen and the lamina propria. Woods (1976), also working 
with the TGE virus (TGEV), developed a leukocyte aggregation assay 
based on recirculating memory lymphocytes. Shimizu and Shimizu (1979a, 
1979b), using an dji vitro proliferative assay for lymphocytes isolated 
from the peripheral blood, gpleen, Peyer's patches and mesenteric lymph 
nodes, found these lymphocytes to be reactive to TGEV antigen ^  vitro. 
The same researchers demonstrated cytotoxicity to TGEV infected target 
cells with lymphocytes isolated from the various sites. Both pro­
liferation and cytotoxicity were depressed after treatment with anti-
porcine thymocyte serum plus complement, indicating that the lymphocytic 
reactivity to viral antigen in pigs orally exposed to TGEV was largely 
T-lymphocyte dependent. Valentine (1971) reported that the lymphocyte 
proliferation assay is an in vitro correlate of delayed type 
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hypersensitivity. Thus, it may be possible to regard the lymphocyte 
proliferative response as one of the vitro correlates of CMI in 
pigs infected with TGEV. 
Classical immunology holds that immunization by various routes 
elicits different responses. Frederick and Bohl (1976) discovered, 
following oral inoculations of TGEV, that lymphocytes from the lamina 
propria produced more MIF than did splenic lymphocytes, and that 
following subcutaneous inoculation the opposite result was observed. 
Bohl et al. (1972) showed that intramuscular (IM)Infection of TGEV 
into gilts resulted in high serum and colostral IgG titers but very low 
titers of IgA. Natural infection of gilts stimulated high serum and 
colostral IgA titers. Shimizu and Shimizu (1979a) demonstrated both 
local and systemic CMI when pigs were orally exposed to the virulent 
TGE virus. Parenteral immunization of pigs with the virus induced only 
systemic CMI. 
Our vitro proliferative lymphocyte assay indicated that the viral 
subunit glycoprotein administered intramuscularly (IM) with adjuvant 
elicited sensitized lymphocytes. The lymphocytes were isolated from 
the peripheral blood, spleen, Peyer's patches, and mesenteric lymph nodes. 
These lymphocytes underwent ^  vitro proliferation in the presence of 
viral antigen, whereas, splenic lymphocytes responded little if at all. 
The failure of splenocytes to be stimulated may, however, be due to 
the time at which the lymphocytes were taken. Peripheral lymphocytes 
which were sensitized to the glycoprotein from the Illinois strain of 
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TGEV readily underwent in vitro blast transformation in response to 
stimulation with glycoprotein from the Miller strain of TGEV. This 
indicates there is a similarity between the two isolated glycoproteins 
from different TGEV strains. 
Through the use of anti-porcine thymocyte serum and complement 
all lymphocyte stimulation was depressed, even that stimulation achieved 
with the T-cell mitogens concanavalin A and phytohemagglutinin. The 
anti-porcine thymocyte serum also inhibited any resetting of porcine 
lymphocytes with sheep red blood cells. 
Subunit vaccines are extremely safe as an alternative to 
immunization of animals with a potentially lethal pathogen. 
However, they require the addition of an adjuvant in order to induce 
a strong immune response. Researchers working with coronaviruses have 
isolated various subunits from them. Some of these subunits are glyco­
sylated, whereas others are not. 
Wege et al. (1979) demonstrated that the coronavirus JHM contains 
six polypeptides in SDS-PA6E. One of these polypeptides has a molecular 
weight of 60,800 and is not glycosylated. Hierholzer et al, (1972) 
discovered a glycosylated subunit of 60,000 molecular weight from the 
human coronavirus OC43. Sturman and Holmes (1977) working with the 
murine coronavirus A-59 found a glycoprotein subunit with an apparent 
molecular weight of 60,000. 
This study using SDS-PAGE revealed that the subunit isolated in 
our laboratory has a molecular weight of 67,000 daltons. Furthermore, 
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the subunit was found to have an isoelectric point of 3.86. The use of 
periodic-Schiff reagent revealed that the viral subunit was glycosylated. 
Further characterization with immunodiffusion, rocket immunoelectro-
phoresis, and cross innnunoelectrophoresis demonstrated that the glyco­
protein from both strains of TGE virus. Miller and Illinois, have one 
common major antigenic component. 
A few of the researchers working with subunit components from the 
coronaviruses have noticed contamination with host material. 
Hierholzer et al. (1972), working with the human coronavirus 0C43, 
confirmed the association of a host cell antigen with the virion by 
means of standard HI and CF tests. Yaseen and Johnson-Lussenburg (1980) 
discovered six coronavirus antigens associated with the human coronavirus 
strain 229E; three were identified as virus specific, whereas, the 
remainder were host antigens. 
In our laboratory anti-TGE ammonium sulfate fractionated serum 
was adsorbed with host material. This adsorbed serum was then used in 
rocket immunoelectrophoresis of both the Miller and Illinois glyco­
proteins. The result indicated that the glycoprotein from both strains 
were of viral nature and not host material. 
In conclusion,a TGE viral subunit vaccine would be advantageous 
in fighting this disease. A demonstration of cross-reactivity both in 
the proliferative assay and in precipitation reactions of glycoprotein 
from both strains indicates similarity if not identity. Thus, this 
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subunit would serve as a useful universal iiranunogen for the different 
strains of TGE virus. 
121 
REFERENCES 
Adams, W. R., and L. M. Kraft. 1968. Electron-microscopic study 
of the intestinal epithelium of mice infected with the agent of 
epizootic diarrhea of infant mice. Am. J. Pathol. 51:39-60. 
Allen, W. D., and P. Porter. 1973. Localization by immunofluorescence 
of secretory component and IgA in the intestinal mucosa of the young 
pig. Immunology 24:365-374. 
Bachmann, P. A., T. Hanichen, K. Banner, and B. Bibrach. 1972. 
Zur Epidemiologie der iibertragbarer Gastroenteritis (TGE) beim 
Schwein. Zentralbl. Veterinarmed. 198:166-174. 
Bohac, J., and J. B. Derbyshire. 1975. The demonstration of trans­
missible gastroenteritis viral antigens by immunoelectrophoresis 
and counterimmunoelectrophoresis. Can. J. Microbiol. 21:750-753. 
Bohl, E. H. 1975. Transmissible gastrienteritis. Pages 168-188 
in H. W. Dunne, and A. D. Leman, eds. Diseases of Swine. 4th ed. 
The Iowa State University Press, Ames, Iowa. 
Bohl, E. H., B. C. Easterday, E. 0. Haelterman, A. W. McClurkin, 
M. Ristic, and T. W. Tamoglia. 1969. Report of subcommittee on 
transmissible gastroenteritis in swine. U.S. Animal Health Assoc. 
Proc. 73:358-360. 
Bohl, E. H., R. K. P. Gupta, L. W. McCouskey, and L. Saif, 1972. 
Immunology of transmissible gastroenteritis. JAVMA 160:543-549. 
Bohl, E. H., and L. Saif. 1975. Passive immunity in transmissible 
gastroenteritis of swine: Immunoglobulin characteristics of 
antibodies in milk after inoculating virus by different routes. 
Infect. Immun. 11:23-32. 
Bourne, F. J. 1976. Humoral immunity in the pig. Vet. Rec. 98: 
499-501. 
Bourne, F. J., and J. Curtis. 1973. The transfer of immunoglobulins 
IgG, IgA and IgM from serum to colostrum and milk in the sow. 
Immunology 24:157-162. 
Brostoff, J., and I. M. Roitt. 1969. Cell-mediated (delayed) 
hypersensitivity in patients with summer hay-fever. Lancet ii: 
1269-1272. 
122 
Brown, P. J., and F. J. Bourne. 1976. Development of immunoglobulin-
containing cell population in intestine, spleen, and mesentefic 
lymph node of the young pig as demonstrated by peroxidase-conjugated 
antiserums. Am. J. Vet. Res. 37:1309-1314. 
Butler, D. G., D. G. Gall, M. H. Kelly, and J. R. Hamilton. 1974. 
Transmissible gastroenteritis; Mechanisms responsible for diarrhea 
in an acute viral enteritis in piglets. J. Clin. Invest. 53: 
1335-1342. 
Caron, G. A., and I. Sarkany. 1966. Role of plasma factors in the 
transformation of peripheral blood lymphocytes into lymphoblasts. 
Nature (London) 210:314-315. 
Cartwright, S. F., H. M. Harris, T. B. Blandford, I. Fincham, and 
M. Gitter. 1965. A cytopathic virus causing a transmissible 
gastroenteritis in swine. I. Isolation and properties. J. Comp. 
Pathol. 75:387-396. 
Chu, R. M., R. D. Glock, R. F. Ross, and D. F. Cox. 1979a. Lymphoid 
tissues of the small intestine of swine from birth to one month of 
age. Am. J. Vet. Res. 40:1713-1719. 
Chu, R. M., R. D. Glock, and R. F. Ross. 1979b. Changes in gut-
associated lymphoid tissues of the small intestine of 8-week old 
pigs infected with transmissible gastroenteritis virus (In preparation). 
Am. J. Vet. Res. 
Cox, J. H., B. Dietzschold, and L. G. Schneider. 1976. Rabies virus 
glycoprotein. II. Biological and serological characterization. 
Infect. Immun. 16:754-759. 
Cross, R. F., and E. M. Bohl. 1968. Some criteria for the field 
diagnosis of porcine transmissible gastroenteritis. JAVMA 154: 
266-272. 
Doyle, L. P., and L. M. Hutchings. 1946. A transmissible gastro­
enteritis in pigs. JAVMA 108:257-259. 
Dutton, R. W. 1967. In vitro studies of immunological responses 
of lymphoid cells. Pages 253-336 F. J. Dixon Jr. and H. G. 
Kunkel, eds. Advances in Immunology. Academic Press, Inc. New York, NY. 
Dutton, R. W., and J. D. Eady. 1964. An in vitro system for the study 
of the mechanism of antigenic stimulation in the secondary response. 
Immunology 7:40-53. 
123 
Eco, M., T. Ichihara, T. Tsunoda, and S. Watanabe. 1962. Outbreaks 
of transmissible gastroenteritis among swine in the Kyushu region. 
J. Jpn. Vet. Med. Assoc. 15:16-20. 
Fellner, M. J., F. L. Baer, C. S. Ripps, and K. Hirschhorn. 1967. 
Response of lymphocytes to penicillin: Comparison with skin tests 
and circulating antibodies in man. Nature (London) 216:803-804. 
Frederick, G. T., and E. H. Bohl. 1976. Local and systemic cell-
mediated immunity against transmissible gastroenteritis, an 
intestinal viral infection of swine. J. Immunol. 116:1000-1004. 
Garwes, D. J., and D. H. Pocock. 1975. The polypeptide structure 
of transmissible gastroenteritis virus. J. Gen. Virol. 29:25-34. 
Garwes, D. J., C. M. Pocock, and B. V. Pike. 1976. Isolation of 
subviral components from transmissible gastroenteritis virus. J. 
Gen. Virol. 32:283-294. 
Girard, J. P., N. R. Rose, M. L. Kunz, S. Kobayashi, and C. E. 
Arbesman. 1967. In vitro lymphocyte transformation in atopic 
patients: induced by antigens. J. Allergy 39:65-81. 
Haelterman, E. 0. 1972. On the pathogenesis of transmissible 
gastroenteritis of swine. JAVMA 160:534-540. 
Hajer, I., and J. Storz. 1978. Antigens of bovine coronavirus 
LY-138 and their diagnostic properties. Am. J. Vet. Res. 39: 
441-444. 
Harada, K., S. Furuuchi, T. Kumagai, and J. Sasahara. 1969. 
Pathogenicity, immunogenicity, and distribution of transmissible 
gastroenteritis virus in pigs. Natl. Inst. Anim. Health Q (Tokyo) 
9:185-192. 
Hierholzer, J. C., E. L. Palmer, S. G. Whitfield, H. S. Kaye, and 
W. R. Dowdle. 1972. Protein composition of coronavirus OC43. 
Virology 48:516-527. 
Hooper, B. E., and E. 0. Haelterman. 1966. Concepts of pathogenesis 
and passive immunity in transmissible gastroenteritis of swine. 
JAVMA 149:1580-1586. 
Johnson, R. H. 1967. Feline panleukopenia virus. IV. Methods for 
obtaining reproducible in vitro results. Res. Vet. Sci. 8:256-264. 
124 
Kelley, J. M., S. V. Emerson, and R. R. Wagner. 1972. The glycoprotein 
of vesicular stomatitis virus is the antigen that gives rise to 
and reacts with neutralizing antibody. J. Virol. 10:1231-1235. 
Kelly, M., D. G. Butler, and J. R. Hamilton. 1972. Transmissible 
gastroenteritis in piglets; A model of infantile viral diarrhea. 
J. Pediatr. 80:925-931. 
Lai, M. M. C., and S. A. Stohlman. 1978. RNA of mouse hepatitis 
virus. J. Virol. 26:236-242. 
Lee, K. M. 1956. Propagation of transmissible gastroenteritis virus 
in tissue culture. Ann. N. Y. Acad. Sci. 66:191-195. 
Loewi, G., A. Temple, and T. L. Vischer. 1968. The immunological 
significance in the guinea-pig of in vitro transformation of lymph 
node, spleen, and peripheral blood lymphocytes. Immunology 14: 
257-264. 
MacNaughton, M. R. 1980. The polypeptides of human and mouse corona-
viruses. Arch. Virol. 63:75-80. 
Mebus, C. A., E. L. Stair, N. R. Underdahl, and M. J. Twiehaus. 1971. 
Pathology of neonatal calf diarrhea induced by a reo-like virus. 
Vet. Pathol. 8:490-505. 
McClurkin, A. W., and J. 0. Norman. 1966. Studies on transmissible 
gastroenteritis of swine. II. Selected characteristics of a 
cytopathogenic virus common to five isolates from transmissible 
gastroenteritis. Can. J. Comp. Med. Vet. Sci. 30:190-198. 
Mills, J. A. 1966. The immunologic significance of antigen induced 
lymphocyte transformation in vitro. J. Immunol. 97:239-247. 
Mishell, R. I., and R. W, Button. 1967. Immunization of dissociated 
spleen cell cultures from normal mice. J. Exp. Med. 126:423-442. 
Moon, H. W. 1971. Epithelial cell migration in the alimentary 
mucosa of the suckling pig. Proc. Soc. Ixp. Biol. Med. 137: 
151-154. 
Moon, H. W. 1978. Mechanisms in the pathogensis of diarrhea: A 
review. JAVMA 172:443-448. 
Morein, B., A. Helenius, K. Simons, R. Pettersson, L. Kaarianinen, 
and V. Schirrmacher. 1978. Effective subunit vaccines against an 
enveloped animal virus. Nature (London) 276:715-718. 
125 
Neurath, A. R., and B. A. Rubin. 1971. Viral structural components 
as immunogens of prophylactic value. Monogr. Virol. 4:1-87. 
Okaniwa, A., and M. Maeda. 1965. Histopathology of transmissible 
gastroenteritis in experimentally infected newborn piglets. I. 
Lesions in the digestive tract. Natl. Inst. Anim. Health Q (Tokyo) 
5:190-201. 
Oppenheim, J. J. 1968. Relationship of in vitro lymphocyte trans­
formation to delayed hypersensitivity in guinea pigs and man. 
Fed. Proc. 27:21-28. 
Oppenheim, J. J., R. A. Wolstencroft, and P. G. H. Cell. 1967. 
Delayed hypersensitivity in the guinea-pig to a protein-hapten 
conjugate and its relationship to in vitro transformation of lymph 
node, spleen, thymus, and peripheral blood lymphocytes. Immunology 
12:89-102. 
Pensaert, M., E. 0. Haelterman, and E. J. Hinsman. 1970. Transmissible 
gastroenteritis of swine; virus intestinal cell interactions. II. 
Electron microscopy of the epithelium in isolated jejunal loops. 
Arch. Gesamte Virusforsch. 31:335-351. 
Porter, P., W. D. Allen, A. J. Blades, J. W. Chidlow, and M. A. Linggood. 
1979. Prophylactic immunization against coll disease through in 
feed vaccination of sows and piglets. 3rd Scandinavian Veterinary 
Workshop on Pig diseases, Finland 1979:1-10. 
Pike, B. v . ,  and D. J. Garwes. 1977. Lipids of transmissible 
gastroenteritis virus and their relation to those of two different 
host cells. J. Gen. Virol. 34:531-535. 
Reed, D. E. 1979. A subunit approach to veterinary viral vaccines. 
U.S. Animal Health Assoc. Proc. 83:94-97. 
Robb, J. A., and C. W. Bond. 1979. Coronaviridae. Pages 193-237 
in H. Fraenkel-Conrat and R. R. Wagner, eds. Comprehensive virology. 
Vol. 14. Plenum Press, New York, N.Y. 
Rodger, S. M., J. A. Cranen, and I. William. 1975. Demonstration 
of reovirus-like particles in intestinal contents of piglets with 
diarrhea. Aust. Vet. J. 51:536. 
Rubin, B. A., and H. Tint. 1975. The development and use of vaccines 
based on studies of virus substructures. Prog. Med. Virol. 21:144-157. 
126 
Schafer, W., and D. P. Bolognesi. 1977. Mammalian C-type oncorna­
viruses: Relationships between viral structural and cell-surface 
antigens and their possible significance in immunological defense 
mechanisms. Contemp. Top. Immunobiol. 6:127-167. 
Schochetman, G., R. H. Stevens, and R. W. Simpson. 1977. Presence 
of infectious polyadenylated RNA in the coronavirus avian infectious 
bronchitis virus. Virology 77:772-782. 
Shepherd, R. W., D. G. Gall, D. G. Butler, and J. F. Hamilton. 1979. 
Determinants of Diarrhea in Viral Enteritis: The role of ion transport 
and epithelial changes in the ileum in transmissible gastroenteritis 
in piglets. Gastroenterology 76:20-24. 
Shimizu, M., and Y. Shimizu. 1979a. Demonstration of cytotoxic 
lymphocytes to virus-infected target cells in pigs inoculated with 
transmissible gastroenteritis virus. Am. J. Vet. Res. 40:208-213. 
Shimizu, M., and Y. Shimizu. 1979b. Lymphocyte proliferative responses 
to viral antigens in pigs infected with transmissible gastroenteritis 
virus. Infect. Immun. 23:239-243. 
Siddell, S. G., H. Wege, A. Barthel, and V. terMeulen. 1980. 
Coronavirus JHM: Cell-free synthesis of structural protein p-60. 
J. Virol. 33:10-17. 
Sokol, F. 1975. Vaccines of the future: Immunogenicity of viral 
components. Pages 129-135 ^  C. Koprowski and H. Koprowski, eds. 
Viruses and Immunity. Academic Press Inc., New York. N.Y. 
Stepanek, J., Z. Pospisil, and E. Mesaros. 1971. Growth activity of 
transmissible gastroenteritis (TGE) virus in primary culture of pig 
kidney cells and pig salivary gland cells. Acta Vet. BRNO 40: 
235-240. 
Sturman, L. S. 1977. Characterization of a Coronavirus. I. Structural 
Proteins; Effects of preparative conditions on the migration of 
protein in polyacrylamide gels. Virology 77:637-649. 
Sturman, L. S., and K. V. Holmes. 1977. Characterization of a 
Coronavirus II. Glycoproteins of the Viral Envelope: Tryptic 
Peptide Analysis. Virology 77:650-660. 
Sturman, L. S., K. V. Holmes, and J. Behnke. 1980. Isolation of 
Coronavirus envelope glycoproteins and interaction with the viral 
nucleocapsid. J. Virol. 33:449-462. 
127 
Tajima, M. 1970. Morphology of transmissible gastroenteritis virus 
of pigs. A possible member of coronaviruses. Arch. Gesamte Virusforsch. 
29:105-108. 
Thake, D. C. 1968. Jejunal epithelium in transmissible gastroenteritis 
of swine. An electron microscopic and histochemical study. Am. J. 
Pathol. 53:149-168, 
Tyrrell, D. A. J., D. J. Alexander, J. D. Almeida, C. H. Cunningham, 
B. C. Easterday, D. J. Garwes, J. C. Hierholzer, A. Kapikian, 
M. R. MacNaughton, and K. Mcintosh. 1978. Coronadviridae: second 
report. Intervirology 10:321-328. 
Valentine, F. T. 1971. The transformation and proliferation of 
lymphocytes in vitro. Pages 6-42 J. P. Revillard, ed. Cell-
Mediated immunity : jji vitro correlates. Karger, Basel. 
Wege, H., A. Muller, and V. terMeulen. 1978. Genomic RNA of the 
murine coronavirus JHM. J. Gen. Virol. 41:217-227. 
Wege, H., H. Wege, K. Nagashima, and V. terMeulen. 1979. Structural 
polypeptides of the murine coronavirus JHM. J. Gen. Virol. 42: 
37-47. 
Welter, C. J. 1965. TGE of swine. I. Propagation of virus in cell 
culture and development of a vaccine. Vet. Med/Small Anim. Clin. 
60:1054-1058. 
Wiktor, T. J., E. Gyorgy, H. D. Schlumberger, F. Sokol, and H. Koprowski. 
1973. Antigenic properties of rabies virus components. J. Immunol. 
110:269-276. 
Witte, K. H., and B. C. Easterday. 1967. Isolation and propagation of 
the virus of transmissible gastroenteritis of pigs in various pig 
cell cultures. Arch. Gesamte Virusfosch. 20:327-350. 
Woods, R. D. 1976. Leukocyte-aggregation assay for transmissible 
gastroenteritis of swine. Am. J. Vet. Res. 37:1405-1408. 
Woods, R. D. 1977. Leukocyte migration-inhibition procedure for 
transmissible gastroenteritis viral antigens. Am. J. Vet. Res. 38: 
1267-1269. 
Yaseen, S. A., and M. Johnson-Lussenburg. 1980. Antigenic studies 
on coronavirus. I. Identification of the structural antigens of 
human coronavirus, strain 229E. Can, J. Microbiol, 27:334-342. 
128 
Zweiman, B., R. W. Besdine, and E. A. Hildreth. 1966. The mitotic 
response induced in sensitive guinea-pigs by tuberculin. Nature 
(London) 212:422-423. 
129 
ACKNOWLEDGEMENTS 
To be wise you must first have reverence for the Lord. If you 
know the Holy One, you have understanding. 
Proverbs 9:10 
The author is truly appreciative to his Lord and God for through 
his divine grace and mercy everything is then possible. 
The author holds special appreciation and gratitude for his 
parents Alex Michael Sagona and Ann Marie Sagona for their support, 
concern and understanding throughout all. 
I am most grateful to Dr. P. M. Cough for her continued patience, 
help and understanding during the course of the research and preparation 
of this manuscript. 
The author also wishes to thank Dr. Donald C. Beitz, Dr. R. D. 
Clock, Dr. D. L. Harris and Dr. Carol M. Warner for serving on my 
committee. 
A very special thanks to the secretaries at VMRI: Norma Lewis, 
Joan Lang, Delores Oliver and Marsha Holmes whose help and kindness 
were very much appreciated. 
I would also like to thank my close friends and fellow graduate 
students Drs. Alice and Albert Chang. 
